agency-4729-3•Ohio Administrative Code 4729:3 — State Board of Pharmacy | Pharmacy Technicians
Ohio Administrative Code 4729:3 — State Board of Pharmacy | Pharmacy Technicians
agency-4729-3Ohio Adm.Code 4729:3Regulation
Chapter 4729:3-1 Pharmacy Technicians
Ohio Adm.Code 4729:3-1-01 Definitions - pharmacy technicians.
As used in this division:
(A) "Abandoned application" means an application for a registration pursuant to this division where the applicant fails to complete all application requirements within thirty days after being notified by the board. An applicant forfeits all fees associated with an abandoned application. The board shall not be required to act on any abandoned application and the application may be destroyed by board staff. If the application is abandoned, the applicant shall be required to reapply for registration, submit the required fee, and comply with the registration requirements in effect at the time of reapplication.
(B) "Addicted to or abusing alcohol or drugs" means the chronic and habitual use of alcohol or the use of a drug of abuse as defined in section 3719.011 of the Revised Code by an individual to the extent that the individual no longer can control the individual's use of alcohol or drugs, the individual is physically or psychologically dependent on alcohol or drugs, or the individual's use or abuse of alcohol or drugs endangers the health, safety, or welfare of the individual or others.
(C) "Board of pharmacy" or "board" means the state board of pharmacy established under Chapter 4729. of the Revised Code.
(D) "Business day" means any day other than Saturday, Sunday or a holiday recognized by the state of Ohio on which the offices of the board of pharmacy are not open for business.
(E) "Certified pharmacy technician" means a person who:
(1) Has completed an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code or has complied with the reciprocity requirements of 4729:3-2-01 of the Administrative Code;
(2) Is registered with the state board of pharmacy;
(3) Practices in this state in accordance with rule 4729:3-3-04 of the Administrative Code; and
(4) Maintains a current pharmacy technician certification from an organization that has been recognized by the board.
(F) "Compounding" has the same meaning as defined in section 4729.01 of the Revised Code and agency 4729 of the Administrative Code.
(G) "Controlled substance" has the same meaning as in section 3719.01 of the Revised Code.
(H) "Current pharmacy technician certification from an organization that has been recognized by the board" pursuant to division (B)(2)(d) of section 4729.90 of the Revised Code means either:
(1) The ExCPT certification provided by the national healthcareer association; or
(2) The pharmacy technician certification board (PTCB) certification.
(I) "Dangerous drug" has the same meaning as in section 4729.01 of the Revised Code.
(J) "Disciplinary action," unless otherwise stated in this division, means any of the following by the drug enforcement administration or licensing agency of any state or jurisdiction, regardless of whether the action occurred by formal proceeding, consent, settlement, or other agreement:
(1) An action to revoke, suspend, restrict, limit, or refuse to grant or renew a license, registration, or certification;
(2) A summary or emergency suspension of a license, registration or certification, of any length, and any subsequent revision to the action;
(3) An administrative fine or money penalty, taken as a result of a formal proceeding, to include any fine or money penalty connected to the delivery of health care services or taken in conjunction with other adverse licensure, registration or certification actions, such as revocation, suspension, censure, reprimand, or probation;
(4) An action to reprimand or place the license, registration, or certification holder on probation;
(5) The issuance of a corrective action plan only if such issuance is in conjunction with other adverse licensure, registration or certification actions, such as revocation, suspension, reprimand, probation, or surrender;
(6) The withdrawal of a renewal application for licensure, registration or certification while under investigation;
(7) The non-renewal of a license, registration or certification while under investigation or to avoid an investigation;
(8) The surrender or other relinquishment of a license, registration or certification in lieu of a formal sanction against a person's license, registration, or certificate, whether permanent or temporary;
(9) In lieu of an adverse licensure, registration or certification action, a licensing agency issues a consent order in which a person agrees not to re-apply for a license, registration, or certification in the future;
(10) An enforceable agreement not to practice or to be placed into inactive or other equivalent status while under investigation or in exchange for not conducting an investigation.
(K) "Direct supervision" or "personal supervision" means a pharmacist shall be physically present in the pharmacy, or in the area where the practice of pharmacy is occurring, to provide personal review and approval of all professional activities. The pharmacist providing personal supervision of a pharmacy technician trainee, registered pharmacy technician, or certified pharmacy technician shall:
(1) Be readily available to answer questions of the technician or trainee;
(2) Make appropriate in-process and end-process verifications of the activities of the technician or trainee; and
(3) Be fully responsible for the practice of the technician or trainee.
(L) "Entering information into and retrieving information from a database or patient profile" as used in section 4729.91 of the Revised Code means to enter new or refill prescription information into a database or patient profile.
(M) "In good standing" means a pharmacist to which all the following apply:
(1) Has not been denied the privilege of supervising pharmacy interns, certified pharmacy technicians, registered pharmacy technicians or pharmacy technician trainees by the board;
(2) Has not been denied a license, registration or certificate by any public agency or licensing agency; and
(3) Does not have a license, registration or certificate limited, suspended, currently on probation, or revoked by any public agency or licensing agency.
(N) "Pharmacist" means an individual who holds a valid pharmacist license in accordance with Chapter 4729. of the Revised Code.
(O) "Pharmacy technician trainee" means a person who:
(1) Intends to enroll or is enrolled in an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code to obtain a registration as a registered or certified pharmacy technician;
(2) Is registered as a pharmacy technician trainee with the state board of pharmacy; and
(3) Practices in this state in accordance with rule 4729:3-3-01 of the Administrative Code.
(P) "Place on probation" means to take action against a license or registration, for a period of time determined by the board, which imposes conditions or other requirements, or suspends or otherwise restricts some or all of the activities in which the licensee or registrant may engage.
(Q)
(1) "Positive identification" means a method of identifying a person that does not rely solely on the use of a private personal identifier such as a password, but must use a secure means of identification that includes any of the following:
(a) A manual signature on a hard copy record;
(b) A magnetic card reader;
(c) A bar code reader;
(d) A biometric method;
(e) A proximity badge reader;
(f) A board approved system of randomly generated personal questions;
(g) A printout of every transaction that is verified and manually signed within a reasonable period of time by the individual who performed the action requiring positive identification. The printout must be maintained for three years and made readily retrievable; or
(h) Other effective methods for identifying individuals that have been approved by the board.
(2) A method relying on a magnetic card reader, a bar code reader, a proximity badge reader, or randomly generated questions for identification must also include a private personal identifier, such as a password, for entry into a secure mechanical or electronic system.
(R) "Refill authorization" means authorization from a prescriber or prescriber's agent for a new non-controlled substance prescription renewal, provided that the prescription remains unchanged.
(S) "Refuse to grant or renew" means to deny original or continued licensure or registration for a period of at least twenty-four months. After twenty-four months, or such period of time as the individual board order may require, a person licensed or registered by the board or a person seeking to attain such status by licensure or registration, and whose license or registration the state board of pharmacy has refused to grant or renew, may make application to the board for issuance of a new license or registration. A person that seeks to attain such status by licensure or registration, whose license or registration the state board of pharmacy has refused to grant or renew, must meet all requirements established by the board in rule and as may be set forth in the person's board order.
(T) "Registered pharmacy technician" means a person who:
(1) Has completed an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code or has complied with the reciprocity requirements of 4729:3-2-01 of the Administrative Code;
(2) Is registered with the state board of pharmacy; and
(3) Practices in this state in accordance with rule 4729:3-3-03 of the Administrative Code.
(U) "Responsible person" has the same meaning as defined in rule 4729:5-2-01 of the Administrative Code.
(V) "Revoke" means to take action against a license or registration rendering such license or registration void and such license or registration shall not be reissued. Revoke is an action that is permanent against the licensee or registrant.
(W) "State" means a state of the United States, the District of Columbia, the Commonwealth of Puerto Rico or a territory or insular possession subject to the jurisdiction of the United States.
(X)
(1) "Support personnel" means the following:
(a) An individual employed or performing contracted services at a location licensed as a terminal distributor of dangerous drugs, trained to perform clerical duties associated with the practice of pharmacy, including pricing, cashiering, drug purchasing, delivering, scheduling deliveries, answering non-professional telephone inquiries, transportation of dispensed medications within a hospital, documenting and processing third-party billing information for reimbursement, or any other activity as determined by the board.
(b) An individual contracted by a terminal distributor of dangerous drugs to perform drug inventories.
(2) Except for those responsible for the delivery of dangerous drugs, support personnel shall not have unsupervised access to dangerous drugs.
(3) Except as provided in paragraphs (X)(4) and (X)(5) of this rule or as otherwise authorized by the board in agency 4729 of the Administrative Code, support personnel shall not perform the tasks of a pharmacist, pharmacy intern, certified pharmacy technician, registered pharmacy technician, or pharmacy technician trainee.
(4) Support personnel may have access to or retrieve information from patient records, including a database or patient profile to perform clerical duties associated with the practice of pharmacy. Support personnel shall not enter prescription information into a patient profile.
(5) Support personnel may perform the following:
(a) Transporting dangerous drugs from a loading dock, warehouse or other area that receives shipments from a licensed wholesaler or other person licensed in accordance with section 4729.52 of the Revised Code;
(b) Stocking and retrieving from inventory non-controlled dangerous drugs that are not dispensed by the pharmacy.
(c) Stocking of automated drug dispensing units and floor stock with intravenous fluids that are non-controlled dangerous drugs and are not dispensed by an institutional pharmacy.
(d) Overwrapping or placing in plastic dangerous drugs that have been compounded or dispensed and appropriately labeled by a terminal distributor of dangerous drugs.
(e) Entering demographic and insurance information into an electronic system to process prescription claims.
(f) Place dangerous drugs dispensed by a pharmacist into shipping containers or packages for delivery if the terminal distributor of dangerous drugs complies with all the following:
(i) Uses barcode scanning and patient order information to ensure the accuracy of the drugs placed into shipping containers or packaging.
(ii) Develops and implements a quality assurance program to track the accuracy of the support personnel packaging the dangerous drugs.
(6) The terminal distributor of dangerous drugs shall be responsible for ensuring all support personnel comply with state and federal requirements to ensure the confidentiality of patient health records.
(7) Support personnel shall not serve as a pharmacist's delegate pursuant to section 4729.80 of the Revised Code.
(8) Support personnel are not required to obtain licensure or registration under Chapter 4729. of the Revised Code.
(Y) "Suspend" means to take action against a license or registration rendering such license or registration without force and effect for a period of time as determined by the state board of pharmacy.
(Z) "Summary suspension" means to take immediate action against a license or registration without a prior hearing rendering such license or registration without force and effect for a period of time as indicated in section 3719.121 of the Revised Code. The board may suspend a license or registration issued pursuant to Chapter 4729. of the Revised Code by utilizing a telephone conference call to review the allegations and take a vote.
(AA) "Veteran" means anyone who is serving or has served under honorable conditions in any component of the armed forces, including the national guard and reserve.
Last updated April 1, 2022 at 8:28 AM
History
- Effective: April 1, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-02
The purpose of this rule is to set standards for pharmacy technician training programs to ensure that graduates of the programs have the basic knowledge and experience in general pharmacy to practice in most pharmacy settings.
(A) The state board of pharmacy hereby approves the following pharmacy technician training programs:
(1) A pharmacy technician training program that holds a current accreditation from the American society of health-system pharmacists/accreditation council for pharmacy education.
(2) A program of training for pharmaceutical technicians conducted by a branch of the Armed Forces of the United States, the Indian health service of the United States department of health and human services, or the United States department of veterans affairs.
(3) An employer-based training program that meets the requirements in paragraph (B) of this rule.
(4) A pharmacy technician training program offered by an Ohio public high school as part of a career-technical education program approved by the Ohio department of education pursuant to section 3317.161 of the Revised Code. Each career-technical education program shall require approval by the state board of pharmacy in accordance with standards adopted by the board. Instructions for obtaining board approval will be made available on the board's website: www.pharmacy.ohio.gov.
(5) Successful completion of a doctor of pharmacy (PharmD) program from an approved school of pharmacy in accordance with rule 4729-5-01 of the Administrative Code if the applicant's graduation date is within five years of an application for registration.
(6) Held an active pharmacist or pharmacy intern license or registration in good standing from a licensing agency of any state or jurisdiction for at least one year within five years of an application for registration.
(B) An employer-based training program shall comply with all the following:
(1) The program shall have a program director. The program director and the employer licensed as a terminal distributor of dangerous drugs shall be accountable for the overall quality of the employer-based training program.
The program director shall be a licensed pharmacist in this or any other state that is in good standing.
(2) The program shall consist of didactic and practical experience training, as follows:
(a) A didactic training component that includes, at a minimum, instruction in all of the following:
(i) Mathematical calculations essential to the duties of a pharmacy technician;
(ii) Federal and state laws, rules, and regulations that affect pharmacy practice, including specific laws, rules, and regulations which address the use of technicians;
(iii) Medical and pharmaceutical terminology, symbols, and abbreviations used in the practice of pharmacy and components of a prescription;
(iv) Preparation, packaging, labeling, and proper storage of dangerous drugs;
(v) Knowledge and skills in areas of science relevant to the pharmacy technician's role, including pharmacology;
(vi) Medication safety and error prevention;
(vii) Maintaining confidentiality of patient information, including the Patient Rights and Health Insurance Portability and Accountability Act (HIPAA);
(viii) Ethical and professional standards of practice;
(ix) Recordkeeping and inventory control; and
(x) Patient and caregiver communication, including communicating with diverse populations.
(b) Didactic training may include self-directed learning experiences, including but not limited to home study, computer programs, internet or web-based courses, or any other coursework approved by the program director.
(c) The program shall ensure the required didactic training evaluates a participant's knowledge of the topics listed in paragraph (B)(2)(a) of this rule. The evaluation must include an examination consisting of a minimum of ninety questions in accordance with testing guidelines adopted by the board. The employer shall have procedures that ensure the security and integrity of the examination materials, describe the testing format, and define the successful completion of an examination, which must be at least seventy-five per cent. The examination shall consist primarily of multiple choice, essay, or short answer questions. The questions on the examination shall not be given to the examinee prior to taking the examination. The answers to the examination must not be given to the examinee prior to or during the examination. The examinee shall agree in writing not to share the questions or answers to the examination with any other person.
(d) The didactic training requirements in paragraph (B)(2)(a) of this rule are waived if the trainee has a current pharmacy technician certification from an organization that has been recognized by the board.
(e) Three hundred hours of practical experience in a pharmacy under the direct supervision of a licensed pharmacist that directly relates to the activities permitted in paragraph (B) of rule 4729:3-3-01 of the Administrative Code.
(3) A written or electronic record of training and education shall be maintained as part of the training program that documents the completion of the training requirements, including the number of practical experience hours completed.
(4) It shall be the responsibility of the terminal distributor of dangerous drugs providing employer-based training to ensure that the documentation provided to pharmacy technician trainees accurately reflects the completion of an approved training program. Failure on the part of the terminal distributor of dangerous drugs to ensure the accuracy of training documentation shall be considered a violation of rule 4729:5-4-01 of the Administrative Code.
(5) The program director must ensure that regular and ongoing assessments of program effectiveness are conducted and use the evaluations for continuous improvement of the program. Measures shall include, but are not limited to, the following:
(a) Program completion; and
(b) Program participant satisfaction.
(6) The program shall maintain the following records for a minimum of three years and shall be furnished to the state board of pharmacy within three business days of receipt of a request from the board:
(a) All technician training records and evaluations;
(b) Program assessments conducted in accordance with this rule.
(7) Employer-based training programs may be subject to audit to ensure compliance with the requirements of this rule.
(a) An employer-based training program subject to audit shall provide all requested documentation demonstrating compliance with this rule within thirty days of a request by the board.
(b) Unless an extension is granted, failure to provide the requested documentation within thirty days of a request by the board may result in the suspension of the approval status of the training program.
(c) After reviewing the training program, the board may return it to the employer for revision. Failure to make the necessary revisions may result in the suspension of the approval status of the training program.
(d) The approval status of a training program may be reinstated only after the employer meets the requirements of this rule and any additional requirements as determined by the board.
(C) In order to perform non-sterile drug compounding, a pharmacy technician trainee shall complete the following training requirements prior to compounding non-sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing non-sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing non-sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this paragraph.
(6) Ensuring pharmacy technician trainees are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(8) The training required pursuant to this paragraph may be used to meet the practical experience hours required in paragraph (B)(2)(e) of this rule.
(D) In order to perform sterile drug compounding, a pharmacy technician trainee shall complete the following training requirements prior to compounding sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <797>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this paragraph.
(6) Ensuring pharmacy technician trainees are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(8) The training required pursuant to this paragraph may be used to meet the practical experience hours required in paragraph (B)(2)(e) of this rule.
(E) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of additional training that is of appropriate breadth and depth to clearly address the competencies for a technician trainee to safely and effectively work in a specific practice setting.
(F) Unless otherwise approved by the board, a board approved training program is only valid for application as a registered pharmacy technician or certified pharmacy technician in accordance with rule 4729:3-2-01 of the Administrative Code if the program was completed within five years of an application for registration.
(G) Paragraph (F) of this rule does not apply in the following circumstances:
(1) An applicant for registration has been actively practicing as a pharmacy technician in this or another state within one year of application to the board; or
(2) An applicant has maintained a current pharmacy technician certification from an organization that has been recognized by the board.
(H) An individual may sit for an examination to obtain a pharmacy technician certification from an organization that has been recognized by the board at any time.
Last updated March 7, 2024 at 7:44 AM
History
- Effective: March 7, 2024
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-04
(A) As used in this rule, "positive identification" has the same meaning as in rule 4729:5-5-01 of the Administrative Code.
(B) A certified pharmacy technician shall wear a name tag or badge which contains the designation "Certified Pharmacy Technician." The required designation may be added to an existing name tag or badge. The name tag or badge and the required designation shall contain lettering of a legible size.
(C) A certified pharmacy technician may, under the direct supervision of a pharmacist, engage in the following activities at a location licensed as a terminal distributor of dangerous drugs to the extent that the activities do not require the exercise of professional judgment:
(1) Accepting new written, faxed or electronic prescription orders from a prescriber or a prescriber's agent. New verbal prescription orders from a prescriber or a prescriber's agent for non-controlled drugs may be accepted pursuant to paragraph (C)(13) of this rule.
(2) Entering information into and retrieving information from a database or patient profile.
(3) Preparing and affixing labels.
(4) Stocking dangerous drugs and retrieving those drugs from inventory.
(5) Counting and pouring dangerous drugs into containers.
(6) Placing dangerous drugs into containers prior to dispensing by a pharmacist.
(7) Non-sterile drug compounding in accordance with the required training in paragraph (D) of this rule.
(8) Sterile drug compounding in accordance with the required training in paragraph (E) of this rule.
(9) Packaging and selling a dangerous drug to a patient or patient representative.
(10) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner.
(11) Stocking automated drug storage systems, floor stock, and crash carts at a location licensed as a terminal distributor of dangerous drugs.
(a) Notwithstanding the definition of direct supervision in rule 4729:3-1-01 of the Administrative Code, a certified pharmacy technician may stock automated drug storage systems, crash carts, and floor stock at a location licensed as a terminal distributor of dangerous drugs if a pharmacist is not physically present at the licensed location and all of the following apply:
(i) A pharmacist is readily available to answer questions of the certified pharmacy technician;
(ii) A pharmacist is responsible for conducting routine verifications of the activities of the certified pharmacy technician to prevent the diversion of dangerous drugs;
(iii) A pharmacist is fully responsible for all activities conducted by the certified pharmacy technician at the licensed location.
(12) Requesting refill authorizations for dangerous drugs from a prescriber or prescriber's agent, so long as there is no change from the original prescription;
(13) Accepting new verbal prescription orders, including refill authorizations, for non-controlled drugs from a prescriber or a prescriber's agent pursuant to all of the following:
(a) The pharmacist on duty who is supervising the activity of the certified pharmacy technician will determine if the technician is competent to receive a verbal order.
(b) The pharmacist on duty who is supervising the activity of the certified pharmacy technician is responsible for the accuracy of a prescription order received by a technician.
(c) The pharmacist on duty must be immediately available to answer questions or discuss the prescription order received by a certified pharmacy technician.
(d) The certified pharmacy technician may not receive a prescription order for a controlled substance.
(e) If applicable, the certified pharmacy technician receiving a prescription order must document the full name of the prescriber's agent.
(f) The receiving certified pharmacy technician shall immediately reduce the prescription order to writing, which may include entering the information directly into a computerized record keeping system, and shall review the prescription with the pharmacist on duty.
(g) Prior to dispensing, positive identification of the receiving certified pharmacy technician and the pharmacist on duty shall be recorded to identify the responsibility for the receipt of the prescription.
(h) The certified pharmacy technician and the pharmacist on duty must meet all other applicable rules for the receipt of new verbal prescription orders pursuant to agency 4729 of the Administrative Code.
(14) Send or receive copies of non-controlled prescriptions pursuant to all of the following:
(a) The pharmacist on duty who is supervising the activity of the certified pharmacy technician will determine if the technician is competent to send or receive a prescription copy.
(b) The pharmacist on duty who is supervising the activity of the certified pharmacy technician is responsible for the accuracy of a prescription copy that is sent or received by a technician.
(c) The pharmacist on duty must be immediately available to answer questions or discuss the prescription copy that is sent or received by a certified pharmacy technician.
(d) The certified pharmacy technician may not send or receive a prescription copy for a controlled substance.
(e) The pharmacist or certified pharmacy technician receiving a prescription copy from a certified pharmacy technician must document the full names of the sending technician and the technician's supervising pharmacist. The receiving technician shall immediately reduce the prescription copy to writing, which may include entering the information directly into a computerized record keeping system, and shall review the prescription with the pharmacist on duty. Prior to dispensing, positive identification of the certified pharmacy technician and the pharmacist on duty shall be recorded to identify the responsibility for the receipt of the copy.
(f) The pharmacist or certified pharmacy technician sending a prescription copy to a certified technician must document the full names of the receiving technician and the technician's supervising pharmacist.
(g) The certified technician and the pharmacist on duty must meet all other applicable rules for the transfer of a prescription copy pursuant agency 4729 of the Administrative Code.
(15) Contacting a prescriber or prescriber's agent to obtain clarification for a prescription order if the clarification does not require the exercise of professional judgment.
(16) Performing diagnostic laboratory testing pursuant to agency 4729 of the Administrative Code.
(D) A certified pharmacy technician may:
(1) Engage in remote entry of prescriptions in accordance rule 4729:5-5-25 of the Administrative Code; or
(2) Engage in remote entry of medication orders in accordance with rule 4729:5-9-02.15 of the Administrative Code.
(E) In order to perform non-sterile drug compounding, a certified pharmacy technician shall complete the following training requirements prior to compounding non-sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>.
(2) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(3) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(4) Ensuring certified pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(5) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(F) In order to perform sterile drug compounding, a certified pharmacy technician shall complete the following training requirements prior to compounding sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <797>.
(2) Sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(3) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(4) Ensuring certified pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(5) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(G) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of policies and procedures for additional training appropriate to duties and responsibilities performed by a certified pharmacy technician as well as an ongoing quality assurance plan to ensure competency.
Last updated April 1, 2022 at 8:30 AM
History
- Effective: April 1, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-01
(A) A pharmacy technician trainee shall wear a name tag or badge which contains the designation "Pharmacy Technician Trainee." The required designation may be added to an existing name tag or badge. The name tag or badge and the required designation shall contain lettering of a legible size.
(B) A pharmacy technician trainee may, under the direct supervision of a pharmacist, engage in the following activities at a location licensed as a terminal distributor of dangerous drugs to the extent that the activities do not require the exercise of professional judgment:
(1) Accepting new written, faxed or electronic prescription orders from a prescriber or a prescriber's agent but shall not include verbal orders;
(2) Entering information into and retrieving information from a database or patient profile;
(3) Preparing and affixing labels;
(4) Stocking dangerous drugs and retrieving those drugs from inventory;
(5) Counting and pouring dangerous drugs into containers;
(6) Placing dangerous drugs into containers prior to dispensing by a pharmacist;
(7) Non-sterile drug compounding following the completion of site-specific training pursuant to rule 4729:3-3-02 of the Administrative Code;
(8) Sterile drug compounding following the completion of a site-specific training pursuant to rule 4729:3-3-02 of the Administrative Code;
(9) Packaging and selling a dangerous drug to a patient or patient representative; and
(10) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner.
(C) A pharmacist is not permitted to supervise more than three pharmacy technician trainees engaging in the activities pursuant to paragraph (B) of this rule at any time, unless otherwise approved by the board.
(D) The number of pharmacy technician trainees supervised by a pharmacist does not limit the number of pharmacy interns that can be supervised by a pharmacist in accordance with rule 4729:2-1-01 of the Administrative Code.
Last updated June 11, 2026 at 11:12 AM
History
- Effective: November 20, 2017
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-03
(A) A registered pharmacy technician shall wear a name tag or badge which contains the designation "Registered Pharmacy Technician." The required designation may be added to an existing name tag or badge. The name tag or badge and the required designation shall contain lettering of a legible size.
(B) A registered pharmacy technician may, under the direct supervision of a pharmacist, engage in the following activities at a location licensed as a terminal distributor of dangerous drugs to the extent that the activities do not require the exercise of professional judgment:
(1) Accepting new written, faxed or electronic prescription orders from a prescriber or a prescriber's agent but shall not include verbal orders;
(2) Requesting refill authorizations for dangerous drugs from a prescriber or prescriber's agent, so long as there is no change from the original prescription;
(3) Entering information into and retrieving information from a database or patient profile;
(4) Preparing and affixing labels;
(5) Stocking dangerous drugs and retrieving those drugs from inventory;
(6) Counting and pouring dangerous drugs into containers;
(7) Placing dangerous drugs into containers prior to dispensing by a pharmacist;
(8) Non-sterile drug compounding in accordance with the required training in paragraph (D) of this rule;
(9) Sterile drug compounding in accordance with the required training in paragraph (E) of this rule;
(10) Packaging and selling a dangerous drug to a patient or patient representative;
(11) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner;
(12) Stocking automated drug storage systems, floor stock, and crash carts at a location licensed as a terminal distributor of dangerous drugs if either of the following applies:
(a) The terminal distributor utilizes barcode administration for restocking the drugs and develops and implements a quality assurance program to ensure the accuracy of the personnel stocking the dangerous drugs; or
(b) For restocking automated drug storage systems only: a pharmacist verifies the final dispensing of a dangerous drug removed from the automated drug storage system.
(C) A registered pharmacy technician may:
(1) Engage in remote entry of prescriptions in accordance rule 4729:5-5-25 of the Administrative Code; or
(2) Engage in remote entry of medication orders in accordance with rule 4729:5-9-02.15 of the Administrative Code.
(D) In order to perform non-sterile drug compounding, a registered pharmacy technician shall complete the following training requirements prior to compounding non-sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing non-sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing non-sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(6) Ensuring registered pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(E) In order to perform sterile drug compounding, a registered pharmacy technician shall complete the following training requirements prior to compounding sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <797>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible persons designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(6) Ensuring registered pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(F) A registered pharmacy technician shall be permitted to perform sterile compounding in accordance with this rule if all the following apply:
(1) The registered pharmacy technician is in the process of studying to obtain technician certification from an organization that has been recognized by the board;
(2) The registered pharmacy technician shall not engage in sterile drug compounding at the location licensed as a terminal distributor of dangerous drugs for longer than eighteen months from the date the technician completed the required sterile compounding training in paragraph (E) of this rule.
(3) A terminal distributor of dangerous drugs that permits a registered pharmacy technician to engage in sterile drug compounding shall develop and implement a process to ensure the registered pharmacy technician does not exceed the time limitation established in paragraph (F)(2) of this rule. The terminal distributor of dangerous drugs shall be accountable for a registered technician found to be in violation of this paragraph.
(G) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of policies and procedures for additional training appropriate to duties and responsibilities performed by a registered pharmacy technician as well as an ongoing quality assurance plan to ensure competency.
Last updated March 7, 2024 at 7:45 AM
History
- Effective: March 7, 2024
- Promulgated Under: 119.03
Chapter 4729:3-2 Registration
Ohio Adm.Code 4729:3-2-01 Registration procedures.
(A) An applicant for registration as a pharmacy technician trainee shall:
(1) Comply with all requirements set forth in section 4729.92 of the Revised Code.
(2) Comply with the criminal records check requirements pursuant to rule 4729:3-2-02 of the Administrative Code.
(3) Submit a complete application for registration, in a manner determined by the board, that includes:
(a) The required application fee established in section 4729.921 of the Revised Code, including any transaction fee as required by section 125.18 of the Revised Code.
(b) Except as provided in paragraph (A)(3)(c) of this rule, documentation, as specified by the board, that the applicant meets both of the following requirements:
(i) Has a high school diploma, a certificate of high school equivalence, a foreign school diploma that is equivalent to a U.S. high school diploma or has been employed continuously since prior to April 8, 2009, as a pharmacy technician without a high school diploma or certificate of high school equivalence; and
(ii) Is at least seventeen years of age.
(c) Notwithstanding the requirements of paragraph (A)(3)(b) of this rule, the board may register as a pharmacy technician trainee an applicant who is seventeen or eighteen years of age and does not possess a high school diploma or certificate of high school equivalence if the applicant is enrolled in a career-technical school program that is approved by the board and conducted by a city, exempted village, local, or joint vocational school district.
(d) Any additional information or documentation as determined by the board.
(4) A pharmacy technician trainee licensed or registered in another state may apply for registration by reciprocity by complying with the requirements listed in paragraphs (A)(1) to (A)(3) of this rule.
(B) An applicant for registration as a registered pharmacy technician shall:
(1) Comply with all requirements set forth in section 4729.90 of the Revised Code.
(2) Comply with either of the following:
(a) Have completed an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code; or
(b) Hold a pharmacy technician registration or license issued by another state and have actively worked as a pharmacy technician for at least one year within the previous five years of application.
(3) Comply with the criminal records check requirements pursuant to rule 4729:3-2-02 of the Administrative Code.
(4) Submit a complete application for registration, in a manner determined by the board, that includes:
(a) The required application fee established in section 4729.901 of the Revised Code, including any transaction fee as required by section 125.18 of the Revised Code;
(b) Except for applicants currently registered as pharmacy technician trainees, documentation, as specified by the board, that the applicant meets the following requirements:
(i) Has a high school diploma, a certificate of high school equivalence, a foreign school diploma that is equivalent to a U.S. high school diploma or has been employed continuously since prior to April 8, 2009, as a pharmacy technician without a high school diploma or certificate of high school equivalence;
(ii) Is at least eighteen years of age; and
(iii) If the applicant has a foreign school diploma that is equivalent to a U.S. high school diploma, the applicant shall submit evidence of successful completion of the "Test of English as a Foreign Language, Internet-based test" (TOEFL iBT) pursuant to rule 4729:3-2-05 of the Administrative Code.
(c) Paragraph (B)(4)(b)(iii) of this rule shall not apply if the applicant complies with any of the following:
(i) Submits a diploma or transcript demonstrating completion of an associate degree or higher from an accredited college, junior college, community college, or university in the United States.
(ii) Submits verification of active professional license or registration issued under the following chapters of the Revised Code: 4715., 4723., 4725., 4729., 4730., 4731., 4732., 4734., 4741., 4744., 4753., 4755., 4757., 4759., 4760., 4761., 4762., 4774., 4778., 4779., 4783.
(iii) Submits verification of an active professional license or registration from another state that permits the applicant to engage in the same profession, occupation, or occupational activity as any license or registration issued by an agency listed in paragraph (B)(4)(c)(ii) of this rule.
(iv) Submits an attestation signed by the responsible person, or the equivalent in the state where the technician is registered, of the pharmacy where the technician is actively employed or was employed in the five years prior to the date of submission of an application. The responsible person must complete the required attestation form provided by the board and attest to their personal observation that the technician applicant demonstrates the required proficiency (reading, listening, speaking, and writing) in the English language to practice safely and effectively as a registered pharmacy technician.
(v) Submits documentation of any other board approved method for demonstrating English language proficiency.
(d) Any of the following documentation:
(i) An attestation, certificate of completion, or other board approved documentation that the applicant has successfully completed an approved training program in accordance with rule 4729:3-3-02 of the Administrative Code.
(ii) Documentation, as determined by the board, demonstrating compliance with the reciprocity requirements of paragraph (B)(2)(b) of this rule.
(e) Any additional information or documentation as determined by the board.
(C) An applicant for registration as a certified pharmacy technician shall:
(1) Comply with all requirements set forth in section 4729.90 of the Revised Code.
(2) Comply with either of the following:
(a) Have completed an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code;
(b) Hold a pharmacy technician registration or license issued by another state and have actively worked as a pharmacy technician for at least one year within the previous five years of application; or
(c) Holds a current pharmacy technician certification from an organization that has been recognized by the board for at least two years immediately preceding the date the application is submitted and has been actively practicing as a pharmacy technician in a state that does not issue a pharmacy technician license or registration for at least two of the five years immediately preceding the date the application is submitted.
(3) Comply with the criminal records check requirements pursuant to rule 4729:3-2-02 of the Administrative Code.
(4) Submit a complete application for registration, in a manner determined by the board, that includes:
(a) The required application fee established in section 4729.901 of the Revised Code, including any transaction fee as required by section 125.18 of the Revised Code, except as provided in rule 4729:3-2-03 of the Administrative Code;
(b) Documentation, as specified by the board, that the applicant has a current pharmacy technician certification from an organization that has been recognized by the board.
(c) Except for applicants currently registered as pharmacy technician trainees, documentation, as specified by the board, that the applicant meets the following requirements:
(i) Has a high school diploma, a certificate of high school equivalence or a foreign school diploma that is equivalent to a U.S. high school diploma;
(ii) Is at least eighteen years of age; and
(iii) If the applicant has a foreign school diploma that is equivalent to a U.S. high school diploma, the applicant shall submit evidence of successful completion of the "Test of English as a Foreign Language, Internet-based test" (TOEFL iBT) pursuant to rule 4729:3-2-05 of the Administrative Code.
(d) Paragraph (C)(4)(c)(iii) of this rule shall not apply if the applicant complies with either of the following:
(i) Submits a diploma or transcript demonstrating completion of an associate degree or higher from an accredited college, junior college, community college or university in the United States.
(ii) Submits verification of active professional license or registration issued under the following chapters of the Revised Code: 4715., 4723., 4725., 4729., 4730., 4731., 4732., 4734., 4741., 4744., 4753., 4755., 4757., 4759., 4760., 4761., 4762., 4774., 4778., 4779., 4783.
(iii) Submits verification of an active professional license or registration from another state that permits the applicant to engage in the same profession, occupation, or occupational activity as any license or registration issued by an agency listed in paragraph (C)(4)(d)(ii) of this rule.
(iv) Submits an attestation signed by the responsible person, or the equivalent in the state where the technician is registered, of the pharmacy where the technician is actively employed or was employed in the five years prior to the date of submission of an application. The responsible person must complete the required attestation form provided by the board and attest to their personal observation that the technician applicant demonstrates the required proficiency (reading, listening, speaking, and writing) in the English language to practice safely and effectively as a certified pharmacy technician.
(v) Submits documentation of any other board approved method for demonstrating English language proficiency.
(e) Any of the following documentation:
(i) An attestation, certificate of completion, or other board approved documentation that the applicant has successfully completed an approved training program in accordance rule 4729:3-3-02 of the Administrative Code.
(ii) Documentation, as determined by the board, demonstrating compliance with the reciprocity requirements of paragraphs (C)(2)(b) and (C)(2)(c) of this rule.
(f) Any additional information or documentation as determined by the board.
(D) Pursuant to section 4729.921 of the Revised Code, a registration for a pharmacy technician trainee is valid for eighteen months from the date of issuance.
(E) A pharmacy technician trainee that fails to meet the education and training requirements during the trainee's initial registration period, may apply for reinstatement of their registration by submitting an application and fee as required by paragraph (A) of this rule. Only one reinstatement shall be granted, but an individual may reapply for registration if the individual's previous registration has lapsed for more than five years or the board grants its approval.
(F) Pursuant to section 4729.96 of the Revised Code, a limited or restricted registration may be issued to an applicant upon the determination of the board.
(G) An initial registration for a registered pharmacy technician and certified pharmacy technician is valid until the renewal date set forth in rule 4729:3-2-03 of the Administrative Code.
(H) Failure to complete all application requirements within thirty days after being notified by the board may result in the application being deemed abandoned as defined in rule 4729:3-1-01 of the Administrative Code.
(I) Registration fees for veterans shall be waived upon submission of the appropriate documentation. Documentation required to obtain a fee waiver will be published on the state board of pharmacy's web site: www.pharmacy.ohio.gov.
Last updated May 15, 2026 at 7:34 AM
History
- Effective: May 15, 2026
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-2-02
(A) An applicant seeking an initial registration, including as registration by reciprocity, as a pharmacy technician trainee, registered pharmacy technician or certified pharmacy technician must first submit fingerprint impressions to the Ohio bureau of criminal identification and investigation (BCI&I) for a criminal records check.
(B) Pursuant to section 4776.02 of the Revised Code, the criminal records check performed by BCI&I shall consist of both a BCI&I criminal records check and a federal bureau of investigation (FBI) criminal records check. BCI&I shall send the results of the BCI&I and FBI criminal records checks directly to the state board of pharmacy.
(C) The state board of pharmacy requires that the criminal records check be based on electronic fingerprint impressions that are submitted directly to BCI&I from a WebCheck provider agency or ink impressions. The state board of pharmacy may accept the results of a criminal records check based on ink impressions only in the following circumstances:
(1) Readable electronic fingerprint impressions cannot be obtained or are rejected by either BCI&I or FBI;
(2) The applicant is from out-of-state; or
(3) The applicant's home address is seventy-five miles or more from the nearest WebCheck location.
(D) Results will only be considered valid if the fingerprint impressions were obtained within twenty-four months of the date the application is received by the board.
Last updated August 16, 2022 at 2:30 PM
History
- Effective: April 1, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-02
The purpose of this rule is to set standards for pharmacy technician training programs to ensure that graduates of the programs have the basic knowledge and experience in general pharmacy to practice in most pharmacy settings.
(A) The state board of pharmacy hereby approves the following pharmacy technician training programs:
(1) A pharmacy technician training program that holds a current accreditation from the American society of health-system pharmacists/accreditation council for pharmacy education.
(2) A program of training for pharmaceutical technicians conducted by a branch of the Armed Forces of the United States, the Indian health service of the United States department of health and human services, or the United States department of veterans affairs.
(3) An employer-based training program that meets the requirements in paragraph (B) of this rule.
(4) A pharmacy technician training program offered by an Ohio public high school as part of a career-technical education program approved by the Ohio department of education pursuant to section 3317.161 of the Revised Code. Each career-technical education program shall require approval by the state board of pharmacy in accordance with standards adopted by the board. Instructions for obtaining board approval will be made available on the board's website: www.pharmacy.ohio.gov.
(5) Successful completion of a doctor of pharmacy (PharmD) program from an approved school of pharmacy in accordance with rule 4729-5-01 of the Administrative Code if the applicant's graduation date is within five years of an application for registration.
(6) Held an active pharmacist or pharmacy intern license or registration in good standing from a licensing agency of any state or jurisdiction for at least one year within five years of an application for registration.
(B) An employer-based training program shall comply with all the following:
(1) The program shall have a program director. The program director and the employer licensed as a terminal distributor of dangerous drugs shall be accountable for the overall quality of the employer-based training program.
The program director shall be a licensed pharmacist in this or any other state that is in good standing.
(2) The program shall consist of didactic and practical experience training, as follows:
(a) A didactic training component that includes, at a minimum, instruction in all of the following:
(i) Mathematical calculations essential to the duties of a pharmacy technician;
(ii) Federal and state laws, rules, and regulations that affect pharmacy practice, including specific laws, rules, and regulations which address the use of technicians;
(iii) Medical and pharmaceutical terminology, symbols, and abbreviations used in the practice of pharmacy and components of a prescription;
(iv) Preparation, packaging, labeling, and proper storage of dangerous drugs;
(v) Knowledge and skills in areas of science relevant to the pharmacy technician's role, including pharmacology;
(vi) Medication safety and error prevention;
(vii) Maintaining confidentiality of patient information, including the Patient Rights and Health Insurance Portability and Accountability Act (HIPAA);
(viii) Ethical and professional standards of practice;
(ix) Recordkeeping and inventory control; and
(x) Patient and caregiver communication, including communicating with diverse populations.
(b) Didactic training may include self-directed learning experiences, including but not limited to home study, computer programs, internet or web-based courses, or any other coursework approved by the program director.
(c) The program shall ensure the required didactic training evaluates a participant's knowledge of the topics listed in paragraph (B)(2)(a) of this rule. The evaluation must include an examination consisting of a minimum of ninety questions in accordance with testing guidelines adopted by the board. The employer shall have procedures that ensure the security and integrity of the examination materials, describe the testing format, and define the successful completion of an examination, which must be at least seventy-five per cent. The examination shall consist primarily of multiple choice, essay, or short answer questions. The questions on the examination shall not be given to the examinee prior to taking the examination. The answers to the examination must not be given to the examinee prior to or during the examination. The examinee shall agree in writing not to share the questions or answers to the examination with any other person.
(d) The didactic training requirements in paragraph (B)(2)(a) of this rule are waived if the trainee has a current pharmacy technician certification from an organization that has been recognized by the board.
(e) Three hundred hours of practical experience in a pharmacy under the direct supervision of a licensed pharmacist that directly relates to the activities permitted in paragraph (B) of rule 4729:3-3-01 of the Administrative Code.
(3) A written or electronic record of training and education shall be maintained as part of the training program that documents the completion of the training requirements, including the number of practical experience hours completed.
(4) It shall be the responsibility of the terminal distributor of dangerous drugs providing employer-based training to ensure that the documentation provided to pharmacy technician trainees accurately reflects the completion of an approved training program. Failure on the part of the terminal distributor of dangerous drugs to ensure the accuracy of training documentation shall be considered a violation of rule 4729:5-4-01 of the Administrative Code.
(5) The program director must ensure that regular and ongoing assessments of program effectiveness are conducted and use the evaluations for continuous improvement of the program. Measures shall include, but are not limited to, the following:
(a) Program completion; and
(b) Program participant satisfaction.
(6) The program shall maintain the following records for a minimum of three years and shall be furnished to the state board of pharmacy within three business days of receipt of a request from the board:
(a) All technician training records and evaluations;
(b) Program assessments conducted in accordance with this rule.
(7) Employer-based training programs may be subject to audit to ensure compliance with the requirements of this rule.
(a) An employer-based training program subject to audit shall provide all requested documentation demonstrating compliance with this rule within thirty days of a request by the board.
(b) Unless an extension is granted, failure to provide the requested documentation within thirty days of a request by the board may result in the suspension of the approval status of the training program.
(c) After reviewing the training program, the board may return it to the employer for revision. Failure to make the necessary revisions may result in the suspension of the approval status of the training program.
(d) The approval status of a training program may be reinstated only after the employer meets the requirements of this rule and any additional requirements as determined by the board.
(C) In order to perform non-sterile drug compounding, a pharmacy technician trainee shall complete the following training requirements prior to compounding non-sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing non-sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing non-sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this paragraph.
(6) Ensuring pharmacy technician trainees are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(8) The training required pursuant to this paragraph may be used to meet the practical experience hours required in paragraph (B)(2)(e) of this rule.
(D) In order to perform sterile drug compounding, a pharmacy technician trainee shall complete the following training requirements prior to compounding sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <797>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this paragraph.
(6) Ensuring pharmacy technician trainees are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(8) The training required pursuant to this paragraph may be used to meet the practical experience hours required in paragraph (B)(2)(e) of this rule.
(E) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of additional training that is of appropriate breadth and depth to clearly address the competencies for a technician trainee to safely and effectively work in a specific practice setting.
(F) Unless otherwise approved by the board, a board approved training program is only valid for application as a registered pharmacy technician or certified pharmacy technician in accordance with rule 4729:3-2-01 of the Administrative Code if the program was completed within five years of an application for registration.
(G) Paragraph (F) of this rule does not apply in the following circumstances:
(1) An applicant for registration has been actively practicing as a pharmacy technician in this or another state within one year of application to the board; or
(2) An applicant has maintained a current pharmacy technician certification from an organization that has been recognized by the board.
(H) An individual may sit for an examination to obtain a pharmacy technician certification from an organization that has been recognized by the board at any time.
Last updated March 7, 2024 at 7:44 AM
History
- Effective: March 7, 2024
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-2-05
Successful completion of the "Test of English as a Foreign Language, Internet-based test" (TOEFL iBT) shall be the following minimum scores or higher:
(A) Writing: fourteen;
(B) Speaking: twenty;
(C) Listening: seventeen; and
(D) Reading: eighteen.
Last updated May 19, 2026 at 3:59 PM
History
- Effective: January 23, 2023
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-2-03
(A) A registered pharmacy technician shall submit a renewal application, in a manner determined by the board, that includes all the following:
(1) An attestation that the technician has completed the specified continuing education requirements pursuant to rule 4729:3-5-01 of the Administrative Code.
(2) The required biennial fee of fifty dollars, except as provided in paragraph (A)(3) of this rule.
(3) A registered pharmacy technician may apply to be a certified pharmacy technician at no cost if the registered technician applies for a certified pharmacy technician registration during the renewal application period established in paragraph (C) of this rule.
(4) Any additional information or documentation as determined by the board.
(B) A certified pharmacy technician shall submit a renewal application, in a manner determined by the board, that includes all the following:
(1) An attestation that the technician has valid technician certification number from an organization that has been recognized by the board and has complied with the continuing education requirements of that organization.
(2) The required biennial fee of fifty dollars.
(3) Any additional information or documentation as determined by the board.
(C) A renewal application for registered pharmacy technicians shall be submitted no later than the thirty first of March of each even-numbered year. Renewal applications shall be accepted no earlier than January of each even-numbered year on a date determined by the board's director of licensing.
An initial registration issued by the state board of pharmacy on or after the first of December of every odd-numbered year in accordance with Chapter 4729. of the Revised Code entitles the individual to whom it is issued to practice as a registered pharmacy technician until the renewal date immediately following the next required renewal date.
(D) A renewal application for certified pharmacy technicians shall be submitted no later than the thirtieth of September of each even-numbered year. Renewal applications shall be accepted no earlier than July of each even-numbered year on a date determined by the board's director of licensing.
An initial registration issued by the state board of pharmacy on or after the first of June of every even-numbered year in accordance with Chapter 4729. of the Revised Code entitles the individual to whom it is issued to practice as a certified pharmacy technician until the renewal date immediately following the next required renewal date.
(E) A registered pharmacy technician or certified pharmacy technician who fails to renew a registration in accordance with this rule is prohibited from engaging in the activities authorized by section 4729.91 of the Revised Code and rules 4729:3-3-03 and 4729:3-3-04 of the Administrative Code.
(F) A registered pharmacy technician or certified pharmacy technician who fails to renew a registration in accordance with this rule, but has not lapsed for more than ninety days, may be renewed if the applicant complies with the following:
(1) Submits a renewal application in accordance with this rule;
(2) Pays the renewal fee and a late fee of fifty dollars.
(G) A registrant that fails to renew for more than ninety days may not renew a registration and the registration shall be considered expired and cannot be renewed. An individual may apply to reinstate a registration in accordance with rule 4729:3-2-01 of this rule.
(H)
(1) In accordance with section 5903.10 of the Revised Code, a holder of an expired registration shall be granted a renewal of the registration by the state board of pharmacy at the usual cost without penalty and without need to meet the requirements set forth in rule 4729:3-2-01 of the Administrative Code if not otherwise disqualified because of mental or physical disability and if either of the following applies:
(a) The registration was not renewed because of the holder's service in the armed forces of the United States or a reserve component of the armed forces.
(b) The registration was not renewed because the holder's spouse served in the armed forces of the United States or a reserve component of the armed forces.
(2) A registered or certified pharmacy technician shall submit proper documentation certifying the active duty service and the length of that active duty service. Documentation required to obtain a renewal pursuant to paragraph (H)(1) of this rule will be published on the state board of pharmacy's web site: www.pharmacy.ohio.gov.
(I) Renewal fees for veterans shall be waived upon submission of the appropriate documentation. Documentation required to obtain a fee waiver will be published on the state board of pharmacy's web site: www.pharmacy.ohio.gov.
Last updated April 1, 2022 at 8:29 AM
History
- Effective: April 1, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-1-01
As used in this division:
(A) "Abandoned application" means an application for a registration pursuant to this division where the applicant fails to complete all application requirements within thirty days after being notified by the board. An applicant forfeits all fees associated with an abandoned application. The board shall not be required to act on any abandoned application and the application may be destroyed by board staff. If the application is abandoned, the applicant shall be required to reapply for registration, submit the required fee, and comply with the registration requirements in effect at the time of reapplication.
(B) "Addicted to or abusing alcohol or drugs" means the chronic and habitual use of alcohol or the use of a drug of abuse as defined in section 3719.011 of the Revised Code by an individual to the extent that the individual no longer can control the individual's use of alcohol or drugs, the individual is physically or psychologically dependent on alcohol or drugs, or the individual's use or abuse of alcohol or drugs endangers the health, safety, or welfare of the individual or others.
(C) "Board of pharmacy" or "board" means the state board of pharmacy established under Chapter 4729. of the Revised Code.
(D) "Business day" means any day other than Saturday, Sunday or a holiday recognized by the state of Ohio on which the offices of the board of pharmacy are not open for business.
(E) "Certified pharmacy technician" means a person who:
(1) Has completed an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code or has complied with the reciprocity requirements of 4729:3-2-01 of the Administrative Code;
(2) Is registered with the state board of pharmacy;
(3) Practices in this state in accordance with rule 4729:3-3-04 of the Administrative Code; and
(4) Maintains a current pharmacy technician certification from an organization that has been recognized by the board.
(F) "Compounding" has the same meaning as defined in section 4729.01 of the Revised Code and agency 4729 of the Administrative Code.
(G) "Controlled substance" has the same meaning as in section 3719.01 of the Revised Code.
(H) "Current pharmacy technician certification from an organization that has been recognized by the board" pursuant to division (B)(2)(d) of section 4729.90 of the Revised Code means either:
(1) The ExCPT certification provided by the national healthcareer association; or
(2) The pharmacy technician certification board (PTCB) certification.
(I) "Dangerous drug" has the same meaning as in section 4729.01 of the Revised Code.
(J) "Disciplinary action," unless otherwise stated in this division, means any of the following by the drug enforcement administration or licensing agency of any state or jurisdiction, regardless of whether the action occurred by formal proceeding, consent, settlement, or other agreement:
(1) An action to revoke, suspend, restrict, limit, or refuse to grant or renew a license, registration, or certification;
(2) A summary or emergency suspension of a license, registration or certification, of any length, and any subsequent revision to the action;
(3) An administrative fine or money penalty, taken as a result of a formal proceeding, to include any fine or money penalty connected to the delivery of health care services or taken in conjunction with other adverse licensure, registration or certification actions, such as revocation, suspension, censure, reprimand, or probation;
(4) An action to reprimand or place the license, registration, or certification holder on probation;
(5) The issuance of a corrective action plan only if such issuance is in conjunction with other adverse licensure, registration or certification actions, such as revocation, suspension, reprimand, probation, or surrender;
(6) The withdrawal of a renewal application for licensure, registration or certification while under investigation;
(7) The non-renewal of a license, registration or certification while under investigation or to avoid an investigation;
(8) The surrender or other relinquishment of a license, registration or certification in lieu of a formal sanction against a person's license, registration, or certificate, whether permanent or temporary;
(9) In lieu of an adverse licensure, registration or certification action, a licensing agency issues a consent order in which a person agrees not to re-apply for a license, registration, or certification in the future;
(10) An enforceable agreement not to practice or to be placed into inactive or other equivalent status while under investigation or in exchange for not conducting an investigation.
(K) "Direct supervision" or "personal supervision" means a pharmacist shall be physically present in the pharmacy, or in the area where the practice of pharmacy is occurring, to provide personal review and approval of all professional activities. The pharmacist providing personal supervision of a pharmacy technician trainee, registered pharmacy technician, or certified pharmacy technician shall:
(1) Be readily available to answer questions of the technician or trainee;
(2) Make appropriate in-process and end-process verifications of the activities of the technician or trainee; and
(3) Be fully responsible for the practice of the technician or trainee.
(L) "Entering information into and retrieving information from a database or patient profile" as used in section 4729.91 of the Revised Code means to enter new or refill prescription information into a database or patient profile.
(M) "In good standing" means a pharmacist to which all the following apply:
(1) Has not been denied the privilege of supervising pharmacy interns, certified pharmacy technicians, registered pharmacy technicians or pharmacy technician trainees by the board;
(2) Has not been denied a license, registration or certificate by any public agency or licensing agency; and
(3) Does not have a license, registration or certificate limited, suspended, currently on probation, or revoked by any public agency or licensing agency.
(N) "Pharmacist" means an individual who holds a valid pharmacist license in accordance with Chapter 4729. of the Revised Code.
(O) "Pharmacy technician trainee" means a person who:
(1) Intends to enroll or is enrolled in an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code to obtain a registration as a registered or certified pharmacy technician;
(2) Is registered as a pharmacy technician trainee with the state board of pharmacy; and
(3) Practices in this state in accordance with rule 4729:3-3-01 of the Administrative Code.
(P) "Place on probation" means to take action against a license or registration, for a period of time determined by the board, which imposes conditions or other requirements, or suspends or otherwise restricts some or all of the activities in which the licensee or registrant may engage.
(Q)
(1) "Positive identification" means a method of identifying a person that does not rely solely on the use of a private personal identifier such as a password, but must use a secure means of identification that includes any of the following:
(a) A manual signature on a hard copy record;
(b) A magnetic card reader;
(c) A bar code reader;
(d) A biometric method;
(e) A proximity badge reader;
(f) A board approved system of randomly generated personal questions;
(g) A printout of every transaction that is verified and manually signed within a reasonable period of time by the individual who performed the action requiring positive identification. The printout must be maintained for three years and made readily retrievable; or
(h) Other effective methods for identifying individuals that have been approved by the board.
(2) A method relying on a magnetic card reader, a bar code reader, a proximity badge reader, or randomly generated questions for identification must also include a private personal identifier, such as a password, for entry into a secure mechanical or electronic system.
(R) "Refill authorization" means authorization from a prescriber or prescriber's agent for a new non-controlled substance prescription renewal, provided that the prescription remains unchanged.
(S) "Refuse to grant or renew" means to deny original or continued licensure or registration for a period of at least twenty-four months. After twenty-four months, or such period of time as the individual board order may require, a person licensed or registered by the board or a person seeking to attain such status by licensure or registration, and whose license or registration the state board of pharmacy has refused to grant or renew, may make application to the board for issuance of a new license or registration. A person that seeks to attain such status by licensure or registration, whose license or registration the state board of pharmacy has refused to grant or renew, must meet all requirements established by the board in rule and as may be set forth in the person's board order.
(T) "Registered pharmacy technician" means a person who:
(1) Has completed an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code or has complied with the reciprocity requirements of 4729:3-2-01 of the Administrative Code;
(2) Is registered with the state board of pharmacy; and
(3) Practices in this state in accordance with rule 4729:3-3-03 of the Administrative Code.
(U) "Responsible person" has the same meaning as defined in rule 4729:5-2-01 of the Administrative Code.
(V) "Revoke" means to take action against a license or registration rendering such license or registration void and such license or registration shall not be reissued. Revoke is an action that is permanent against the licensee or registrant.
(W) "State" means a state of the United States, the District of Columbia, the Commonwealth of Puerto Rico or a territory or insular possession subject to the jurisdiction of the United States.
(X)
(1) "Support personnel" means the following:
(a) An individual employed or performing contracted services at a location licensed as a terminal distributor of dangerous drugs, trained to perform clerical duties associated with the practice of pharmacy, including pricing, cashiering, drug purchasing, delivering, scheduling deliveries, answering non-professional telephone inquiries, transportation of dispensed medications within a hospital, documenting and processing third-party billing information for reimbursement, or any other activity as determined by the board.
(b) An individual contracted by a terminal distributor of dangerous drugs to perform drug inventories.
(2) Except for those responsible for the delivery of dangerous drugs, support personnel shall not have unsupervised access to dangerous drugs.
(3) Except as provided in paragraphs (X)(4) and (X)(5) of this rule or as otherwise authorized by the board in agency 4729 of the Administrative Code, support personnel shall not perform the tasks of a pharmacist, pharmacy intern, certified pharmacy technician, registered pharmacy technician, or pharmacy technician trainee.
(4) Support personnel may have access to or retrieve information from patient records, including a database or patient profile to perform clerical duties associated with the practice of pharmacy. Support personnel shall not enter prescription information into a patient profile.
(5) Support personnel may perform the following:
(a) Transporting dangerous drugs from a loading dock, warehouse or other area that receives shipments from a licensed wholesaler or other person licensed in accordance with section 4729.52 of the Revised Code;
(b) Stocking and retrieving from inventory non-controlled dangerous drugs that are not dispensed by the pharmacy.
(c) Stocking of automated drug dispensing units and floor stock with intravenous fluids that are non-controlled dangerous drugs and are not dispensed by an institutional pharmacy.
(d) Overwrapping or placing in plastic dangerous drugs that have been compounded or dispensed and appropriately labeled by a terminal distributor of dangerous drugs.
(e) Entering demographic and insurance information into an electronic system to process prescription claims.
(f) Place dangerous drugs dispensed by a pharmacist into shipping containers or packages for delivery if the terminal distributor of dangerous drugs complies with all the following:
(i) Uses barcode scanning and patient order information to ensure the accuracy of the drugs placed into shipping containers or packaging.
(ii) Develops and implements a quality assurance program to track the accuracy of the support personnel packaging the dangerous drugs.
(6) The terminal distributor of dangerous drugs shall be responsible for ensuring all support personnel comply with state and federal requirements to ensure the confidentiality of patient health records.
(7) Support personnel shall not serve as a pharmacist's delegate pursuant to section 4729.80 of the Revised Code.
(8) Support personnel are not required to obtain licensure or registration under Chapter 4729. of the Revised Code.
(Y) "Suspend" means to take action against a license or registration rendering such license or registration without force and effect for a period of time as determined by the state board of pharmacy.
(Z) "Summary suspension" means to take immediate action against a license or registration without a prior hearing rendering such license or registration without force and effect for a period of time as indicated in section 3719.121 of the Revised Code. The board may suspend a license or registration issued pursuant to Chapter 4729. of the Revised Code by utilizing a telephone conference call to review the allegations and take a vote.
(AA) "Veteran" means anyone who is serving or has served under honorable conditions in any component of the armed forces, including the national guard and reserve.
Last updated April 1, 2022 at 8:28 AM
History
- Effective: April 1, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-5-01
As used in Chapter 4729:3-5 of the Administrative Code.
(A) "A.C.P.E." means the accreditation council for pharmacy education.
(B) "Continuing education unit" or "C.E.U." means ten contact hours of participation in an organized continuing pharmacy education experience presented by an approved provider.
(C) "Continuing pharmacy education" or "continuing education", as required in section 4729.12 of the Revised Code, means post-registration pharmacy education undertaken to maintain professional competency to practice as a pharmacy technician, improve professional skills, and preserve uniform qualifications for continuing the practice of the profession for the purpose of protecting public health and welfare. Continuing pharmacy education may be obtained from any of the following providers:
(1) A pharmacy jurisprudence program pursuant to paragraph (E) of this rule;
(2) An approved in-state provider of volunteer healthcare services in accordance with section 4745.04 of the Revised Code and Chapter 4729-6 of the Administrative Code;
(3) An A.C.P.E. accredited continuing education provider.
(D) "One-third of a licensee's continuing education requirement" as used in division (C) of section 4745.04 of the Revised Code and paragraph (C) of rule 4729:3-5-02 of the Administrative Code, means the total number of required C.E.U.s for licensure renewal divided by three and rounded down to the nearest whole number.
(E) "Pharmacy jurisprudence" means continuing education the includes any of the following:
(1) An A.C.P.E. law program as identified by A.C.P.E numbering convention "03";
(2) A board of pharmacy approved continuing education program provided by an in-state approved jurisprudence provider pursuant to Chapter 4729-6 of the Administrative Code that pertains to current or recent changes to laws, rules, and regulations relating to the practice of pharmacy; or
(3) A program presented by the state board of pharmacy that pertains to current or recent changes to laws, rules, and regulations relating to the practice of pharmacy.
(F) "Patient or medication safety" means an A.C.P.E. continuing education program identified by the A.C.P.E. numbering convention "05" that pertains to the prevention of healthcare errors and the elimination or mitigation of patient injury caused by healthcare errors.
(G) "Veteran" means anyone who is serving or has served under honorable conditions in any component of the armed forces, including the national guard and reserve.
Last updated May 15, 2026 at 7:33 AM
History
- Effective: May 15, 2026
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-03
(A) A registered pharmacy technician shall wear a name tag or badge which contains the designation "Registered Pharmacy Technician." The required designation may be added to an existing name tag or badge. The name tag or badge and the required designation shall contain lettering of a legible size.
(B) A registered pharmacy technician may, under the direct supervision of a pharmacist, engage in the following activities at a location licensed as a terminal distributor of dangerous drugs to the extent that the activities do not require the exercise of professional judgment:
(1) Accepting new written, faxed or electronic prescription orders from a prescriber or a prescriber's agent but shall not include verbal orders;
(2) Requesting refill authorizations for dangerous drugs from a prescriber or prescriber's agent, so long as there is no change from the original prescription;
(3) Entering information into and retrieving information from a database or patient profile;
(4) Preparing and affixing labels;
(5) Stocking dangerous drugs and retrieving those drugs from inventory;
(6) Counting and pouring dangerous drugs into containers;
(7) Placing dangerous drugs into containers prior to dispensing by a pharmacist;
(8) Non-sterile drug compounding in accordance with the required training in paragraph (D) of this rule;
(9) Sterile drug compounding in accordance with the required training in paragraph (E) of this rule;
(10) Packaging and selling a dangerous drug to a patient or patient representative;
(11) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner;
(12) Stocking automated drug storage systems, floor stock, and crash carts at a location licensed as a terminal distributor of dangerous drugs if either of the following applies:
(a) The terminal distributor utilizes barcode administration for restocking the drugs and develops and implements a quality assurance program to ensure the accuracy of the personnel stocking the dangerous drugs; or
(b) For restocking automated drug storage systems only: a pharmacist verifies the final dispensing of a dangerous drug removed from the automated drug storage system.
(C) A registered pharmacy technician may:
(1) Engage in remote entry of prescriptions in accordance rule 4729:5-5-25 of the Administrative Code; or
(2) Engage in remote entry of medication orders in accordance with rule 4729:5-9-02.15 of the Administrative Code.
(D) In order to perform non-sterile drug compounding, a registered pharmacy technician shall complete the following training requirements prior to compounding non-sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing non-sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing non-sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(6) Ensuring registered pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(E) In order to perform sterile drug compounding, a registered pharmacy technician shall complete the following training requirements prior to compounding sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <797>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible persons designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(6) Ensuring registered pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(F) A registered pharmacy technician shall be permitted to perform sterile compounding in accordance with this rule if all the following apply:
(1) The registered pharmacy technician is in the process of studying to obtain technician certification from an organization that has been recognized by the board;
(2) The registered pharmacy technician shall not engage in sterile drug compounding at the location licensed as a terminal distributor of dangerous drugs for longer than eighteen months from the date the technician completed the required sterile compounding training in paragraph (E) of this rule.
(3) A terminal distributor of dangerous drugs that permits a registered pharmacy technician to engage in sterile drug compounding shall develop and implement a process to ensure the registered pharmacy technician does not exceed the time limitation established in paragraph (F)(2) of this rule. The terminal distributor of dangerous drugs shall be accountable for a registered technician found to be in violation of this paragraph.
(G) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of policies and procedures for additional training appropriate to duties and responsibilities performed by a registered pharmacy technician as well as an ongoing quality assurance plan to ensure competency.
Last updated March 7, 2024 at 7:45 AM
History
- Effective: March 7, 2024
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-04
(A) As used in this rule, "positive identification" has the same meaning as in rule 4729:5-5-01 of the Administrative Code.
(B) A certified pharmacy technician shall wear a name tag or badge which contains the designation "Certified Pharmacy Technician." The required designation may be added to an existing name tag or badge. The name tag or badge and the required designation shall contain lettering of a legible size.
(C) A certified pharmacy technician may, under the direct supervision of a pharmacist, engage in the following activities at a location licensed as a terminal distributor of dangerous drugs to the extent that the activities do not require the exercise of professional judgment:
(1) Accepting new written, faxed or electronic prescription orders from a prescriber or a prescriber's agent. New verbal prescription orders from a prescriber or a prescriber's agent for non-controlled drugs may be accepted pursuant to paragraph (C)(13) of this rule.
(2) Entering information into and retrieving information from a database or patient profile.
(3) Preparing and affixing labels.
(4) Stocking dangerous drugs and retrieving those drugs from inventory.
(5) Counting and pouring dangerous drugs into containers.
(6) Placing dangerous drugs into containers prior to dispensing by a pharmacist.
(7) Non-sterile drug compounding in accordance with the required training in paragraph (D) of this rule.
(8) Sterile drug compounding in accordance with the required training in paragraph (E) of this rule.
(9) Packaging and selling a dangerous drug to a patient or patient representative.
(10) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner.
(11) Stocking automated drug storage systems, floor stock, and crash carts at a location licensed as a terminal distributor of dangerous drugs.
(a) Notwithstanding the definition of direct supervision in rule 4729:3-1-01 of the Administrative Code, a certified pharmacy technician may stock automated drug storage systems, crash carts, and floor stock at a location licensed as a terminal distributor of dangerous drugs if a pharmacist is not physically present at the licensed location and all of the following apply:
(i) A pharmacist is readily available to answer questions of the certified pharmacy technician;
(ii) A pharmacist is responsible for conducting routine verifications of the activities of the certified pharmacy technician to prevent the diversion of dangerous drugs;
(iii) A pharmacist is fully responsible for all activities conducted by the certified pharmacy technician at the licensed location.
(12) Requesting refill authorizations for dangerous drugs from a prescriber or prescriber's agent, so long as there is no change from the original prescription;
(13) Accepting new verbal prescription orders, including refill authorizations, for non-controlled drugs from a prescriber or a prescriber's agent pursuant to all of the following:
(a) The pharmacist on duty who is supervising the activity of the certified pharmacy technician will determine if the technician is competent to receive a verbal order.
(b) The pharmacist on duty who is supervising the activity of the certified pharmacy technician is responsible for the accuracy of a prescription order received by a technician.
(c) The pharmacist on duty must be immediately available to answer questions or discuss the prescription order received by a certified pharmacy technician.
(d) The certified pharmacy technician may not receive a prescription order for a controlled substance.
(e) If applicable, the certified pharmacy technician receiving a prescription order must document the full name of the prescriber's agent.
(f) The receiving certified pharmacy technician shall immediately reduce the prescription order to writing, which may include entering the information directly into a computerized record keeping system, and shall review the prescription with the pharmacist on duty.
(g) Prior to dispensing, positive identification of the receiving certified pharmacy technician and the pharmacist on duty shall be recorded to identify the responsibility for the receipt of the prescription.
(h) The certified pharmacy technician and the pharmacist on duty must meet all other applicable rules for the receipt of new verbal prescription orders pursuant to agency 4729 of the Administrative Code.
(14) Send or receive copies of non-controlled prescriptions pursuant to all of the following:
(a) The pharmacist on duty who is supervising the activity of the certified pharmacy technician will determine if the technician is competent to send or receive a prescription copy.
(b) The pharmacist on duty who is supervising the activity of the certified pharmacy technician is responsible for the accuracy of a prescription copy that is sent or received by a technician.
(c) The pharmacist on duty must be immediately available to answer questions or discuss the prescription copy that is sent or received by a certified pharmacy technician.
(d) The certified pharmacy technician may not send or receive a prescription copy for a controlled substance.
(e) The pharmacist or certified pharmacy technician receiving a prescription copy from a certified pharmacy technician must document the full names of the sending technician and the technician's supervising pharmacist. The receiving technician shall immediately reduce the prescription copy to writing, which may include entering the information directly into a computerized record keeping system, and shall review the prescription with the pharmacist on duty. Prior to dispensing, positive identification of the certified pharmacy technician and the pharmacist on duty shall be recorded to identify the responsibility for the receipt of the copy.
(f) The pharmacist or certified pharmacy technician sending a prescription copy to a certified technician must document the full names of the receiving technician and the technician's supervising pharmacist.
(g) The certified technician and the pharmacist on duty must meet all other applicable rules for the transfer of a prescription copy pursuant agency 4729 of the Administrative Code.
(15) Contacting a prescriber or prescriber's agent to obtain clarification for a prescription order if the clarification does not require the exercise of professional judgment.
(16) Performing diagnostic laboratory testing pursuant to agency 4729 of the Administrative Code.
(D) A certified pharmacy technician may:
(1) Engage in remote entry of prescriptions in accordance rule 4729:5-5-25 of the Administrative Code; or
(2) Engage in remote entry of medication orders in accordance with rule 4729:5-9-02.15 of the Administrative Code.
(E) In order to perform non-sterile drug compounding, a certified pharmacy technician shall complete the following training requirements prior to compounding non-sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>.
(2) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(3) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(4) Ensuring certified pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(5) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(F) In order to perform sterile drug compounding, a certified pharmacy technician shall complete the following training requirements prior to compounding sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <797>.
(2) Sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(3) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(4) Ensuring certified pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(5) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(G) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of policies and procedures for additional training appropriate to duties and responsibilities performed by a certified pharmacy technician as well as an ongoing quality assurance plan to ensure competency.
Last updated April 1, 2022 at 8:30 AM
History
- Effective: April 1, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-2-04 Change of name, contact information and place of employment.
(A) An individual registered pursuant to this division who has a legal change of name, shall notify the board of pharmacy within thirty days from the effective date of such change. Such notification of a name change shall be accompanied by one of the following:
(1) A notarized affidavit;
(2) A certified copy of a court record;
(3) A certified copy of a marriage certificate;
(4) A government-issued identification card which reflects the registrant's name change; or
(5) Any other documentation as approved by the board.
(B) An individual registered pursuant to this division who changes their mailing or email address shall notify the board of pharmacy, in a manner determined by the board, of the new address within thirty days after the effective date of such change.
(C) An individual registered pursuant to this division who changes their place of employment shall notify the board of pharmacy, in a manner determined by the board, of the address of the principal place where they practice as a pharmacy technician trainee, registered pharmacy technician, or certified pharmacy technician within thirty days after they have commenced employment.
Last updated May 15, 2026 at 7:32 AM
History
- Effective: May 15, 2026
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-2-06 Expedited pharmacy technician registration for members of the military and spouses who are licensed or registered in another jurisdiction.
(A) As used in this rule:
(1) "Military duty" has the same meaning as in section 4743.041 of the Revised Code.
(2) "In good standing" means an applicant to which both the following apply:
(a) Has not been denied a license, registration, or certificate by any public agency or licensing agency; and
(b) Does not have a license, registration, or certificate limited, suspended, or revoked by any public agency or licensing agency.
(3) "Pharmacy technician" means any of the following registration types issued under Chapter 4729. of the Revised Code:
(a) Certified pharmacy technician;
(b) Registered pharmacy technician; or
(c) Pharmacy technician trainee.
(B) To meet the requirements set forth in section 4743.041 of the Revised Code, the state board of pharmacy shall issue an expedited registration to pharmacy technician applicant if the individual or the individual's spouse is on military duty in this state and the applicant complies with all the following:
(1) The individual holds a valid registration or other authorization to practice as a pharmacy technician issued by any other state or jurisdiction.
(2) The individual shall be in good standing in the state or jurisdiction of licensure or registration.
(3) The individual complies with the application requirements set forth in rule 4729:3-2-01 of the Administrative Code.
(4) The individual presents adequate proof to the board, in accordance with paragraph (G) of this rule, that the individual or the individual's spouse is on military duty in this state.
(5) The individual complies with sections 4776.01 to 4776.04 of the Revised Code. An applicant shall submit fingerprint impressions for a criminal records check in accordance with rule 4729:3-2-02 of the Administrative Code.
(C) The board shall, within twenty-four hours after receiving the report under division (A) of section 4776.04 of the Revised Code, notify an individual applying for an expedited registration in accordance with this rule that the board has received the results of a criminal records check.
(D) The board shall issue an expedited pharmacy technician registration pursuant to this rule, provided that the applicant meets the requirements of this rule, within fourteen days of having received the results of a criminal records check. The board shall not be required to issue an expedited registration if any of the following apply:
(1) The applicant fails to meet the application requirements set forth in this rule or section 4743.041 of the Revised Code.
(2) The applicant is under investigation by the licensing agency of any other state or jurisdiction.
(3) The applicant is in violation of any provision section 4729.96 of the Revised Code or rules adopted thereunder.
(E) Notwithstanding any other provision of the Revised Code or Administrative Code, the board shall waive or refund all fees associated with the issuance of an initial expedited registration issued under this rule. Additional fee waivers or refunds shall be granted in accordance with other provisions of the Revised Code, Administrative Code, and board resolution.
(F) All registrations issued pursuant to this rule shall comply with the registration renewal requirements set forth in Chapter 4729:3-2 of the Administrative Code.
(G) Pursuant to section 5903.04 of the Revised Code:
(1) A pharmacy technician shall submit proper documentation necessary to determine if the applicant is a service member or veteran, or the spouse or surviving spouse of a service member or veteran. Documentation requirements shall be published on the state board of pharmacy's website: www.pharmacy.ohio.gov.
(2) The board's executive director or the director's designee shall design a process to record, track, and monitor applications that have been received from a service member, veteran, or the spouse or surviving spouse of a service member or veteran.
(3) The board's executive director or the director's designee shall design a process to prioritize and expedite certification or licensing for each applicant who is a service member, veteran, or the spouse or a surviving spouse of a service member or veteran.
Last updated May 15, 2026 at 7:32 AM
History
- Effective: May 15, 2026
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-2-07 Holding multiple registrations and licenses.
Unless otherwise approved by the board or the board's executive director:
(A) A person holding a license as a pharmacist or licensed pharmacy intern shall not hold a concurrent license as a pharmacy technician trainee, registered pharmacy technician, or certified pharmacy technician.
(B) Upon receiving an initial license to practice as a pharmacist or pharmacy intern, the person's registration to practice as a pharmacy technician trainee, registered pharmacy technician, or certified pharmacy technician shall be inactivated.
(C) Nothing in this rule prohibits a licensed pharmacist or pharmacy intern from performing the activities of a certified pharmacy technician, registered pharmacy technician, or pharmacy technician trainee.
Last updated April 1, 2022 at 8:29 AM
History
- Effective: April 1, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-2-08 Verification of registration and certification.
(A) In accordance with section 4729.95 of the Revised Code, a terminal distributor of dangerous drugs shall develop and implement a policy to ensure persons holding a technician trainee, registered technician, or certified pharmacy technician registration hold an active registration in accordance with this division of the Administrative Code. The policy shall require, at a minimum, the following:
(1) Documented verification of a technician trainee, registered technician, or certified pharmacy technician registration prior to commencing employment with the terminal distributor of dangerous drugs;
(2) Documented verification of registration, to be conducted at least every twenty-four months, of every technician trainee, registered technician, and certified pharmacy technician employed by the terminal distributor of dangerous drugs; and
(3) Documented verification, to be conducted at least every twenty-four months, of pharmacy technician certification from an organization that has been recognized by the board for all certified pharmacy technicians employed by the terminal distributor of dangerous drugs.
(B) Documented verifications shall be maintained for a period of three years from the date of verification.
Last updated April 1, 2022 at 8:29 AM
History
- Effective: April 1, 2022
- Promulgated Under: 119.03
Chapter 4729:3-3 Practice
Ohio Adm.Code 4729:3-3-01 Pharmacy Technician Trainees.
(A) A pharmacy technician trainee shall wear a name tag or badge which contains the designation "Pharmacy Technician Trainee." The required designation may be added to an existing name tag or badge. The name tag or badge and the required designation shall contain lettering of a legible size.
(B) A pharmacy technician trainee may, under the direct supervision of a pharmacist, engage in the following activities at a location licensed as a terminal distributor of dangerous drugs to the extent that the activities do not require the exercise of professional judgment:
(1) Accepting new written, faxed or electronic prescription orders from a prescriber or a prescriber's agent but shall not include verbal orders;
(2) Entering information into and retrieving information from a database or patient profile;
(3) Preparing and affixing labels;
(4) Stocking dangerous drugs and retrieving those drugs from inventory;
(5) Counting and pouring dangerous drugs into containers;
(6) Placing dangerous drugs into containers prior to dispensing by a pharmacist;
(7) Non-sterile drug compounding following the completion of site-specific training pursuant to rule 4729:3-3-02 of the Administrative Code;
(8) Sterile drug compounding following the completion of a site-specific training pursuant to rule 4729:3-3-02 of the Administrative Code;
(9) Packaging and selling a dangerous drug to a patient or patient representative; and
(10) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner.
(C) A pharmacist is not permitted to supervise more than three pharmacy technician trainees engaging in the activities pursuant to paragraph (B) of this rule at any time, unless otherwise approved by the board.
(D) The number of pharmacy technician trainees supervised by a pharmacist does not limit the number of pharmacy interns that can be supervised by a pharmacist in accordance with rule 4729:2-1-01 of the Administrative Code.
Last updated June 11, 2026 at 11:12 AM
History
- Effective: November 20, 2017
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-02
The purpose of this rule is to set standards for pharmacy technician training programs to ensure that graduates of the programs have the basic knowledge and experience in general pharmacy to practice in most pharmacy settings.
(A) The state board of pharmacy hereby approves the following pharmacy technician training programs:
(1) A pharmacy technician training program that holds a current accreditation from the American society of health-system pharmacists/accreditation council for pharmacy education.
(2) A program of training for pharmaceutical technicians conducted by a branch of the Armed Forces of the United States, the Indian health service of the United States department of health and human services, or the United States department of veterans affairs.
(3) An employer-based training program that meets the requirements in paragraph (B) of this rule.
(4) A pharmacy technician training program offered by an Ohio public high school as part of a career-technical education program approved by the Ohio department of education pursuant to section 3317.161 of the Revised Code. Each career-technical education program shall require approval by the state board of pharmacy in accordance with standards adopted by the board. Instructions for obtaining board approval will be made available on the board's website: www.pharmacy.ohio.gov.
(5) Successful completion of a doctor of pharmacy (PharmD) program from an approved school of pharmacy in accordance with rule 4729-5-01 of the Administrative Code if the applicant's graduation date is within five years of an application for registration.
(6) Held an active pharmacist or pharmacy intern license or registration in good standing from a licensing agency of any state or jurisdiction for at least one year within five years of an application for registration.
(B) An employer-based training program shall comply with all the following:
(1) The program shall have a program director. The program director and the employer licensed as a terminal distributor of dangerous drugs shall be accountable for the overall quality of the employer-based training program.
The program director shall be a licensed pharmacist in this or any other state that is in good standing.
(2) The program shall consist of didactic and practical experience training, as follows:
(a) A didactic training component that includes, at a minimum, instruction in all of the following:
(i) Mathematical calculations essential to the duties of a pharmacy technician;
(ii) Federal and state laws, rules, and regulations that affect pharmacy practice, including specific laws, rules, and regulations which address the use of technicians;
(iii) Medical and pharmaceutical terminology, symbols, and abbreviations used in the practice of pharmacy and components of a prescription;
(iv) Preparation, packaging, labeling, and proper storage of dangerous drugs;
(v) Knowledge and skills in areas of science relevant to the pharmacy technician's role, including pharmacology;
(vi) Medication safety and error prevention;
(vii) Maintaining confidentiality of patient information, including the Patient Rights and Health Insurance Portability and Accountability Act (HIPAA);
(viii) Ethical and professional standards of practice;
(ix) Recordkeeping and inventory control; and
(x) Patient and caregiver communication, including communicating with diverse populations.
(b) Didactic training may include self-directed learning experiences, including but not limited to home study, computer programs, internet or web-based courses, or any other coursework approved by the program director.
(c) The program shall ensure the required didactic training evaluates a participant's knowledge of the topics listed in paragraph (B)(2)(a) of this rule. The evaluation must include an examination consisting of a minimum of ninety questions in accordance with testing guidelines adopted by the board. The employer shall have procedures that ensure the security and integrity of the examination materials, describe the testing format, and define the successful completion of an examination, which must be at least seventy-five per cent. The examination shall consist primarily of multiple choice, essay, or short answer questions. The questions on the examination shall not be given to the examinee prior to taking the examination. The answers to the examination must not be given to the examinee prior to or during the examination. The examinee shall agree in writing not to share the questions or answers to the examination with any other person.
(d) The didactic training requirements in paragraph (B)(2)(a) of this rule are waived if the trainee has a current pharmacy technician certification from an organization that has been recognized by the board.
(e) Three hundred hours of practical experience in a pharmacy under the direct supervision of a licensed pharmacist that directly relates to the activities permitted in paragraph (B) of rule 4729:3-3-01 of the Administrative Code.
(3) A written or electronic record of training and education shall be maintained as part of the training program that documents the completion of the training requirements, including the number of practical experience hours completed.
(4) It shall be the responsibility of the terminal distributor of dangerous drugs providing employer-based training to ensure that the documentation provided to pharmacy technician trainees accurately reflects the completion of an approved training program. Failure on the part of the terminal distributor of dangerous drugs to ensure the accuracy of training documentation shall be considered a violation of rule 4729:5-4-01 of the Administrative Code.
(5) The program director must ensure that regular and ongoing assessments of program effectiveness are conducted and use the evaluations for continuous improvement of the program. Measures shall include, but are not limited to, the following:
(a) Program completion; and
(b) Program participant satisfaction.
(6) The program shall maintain the following records for a minimum of three years and shall be furnished to the state board of pharmacy within three business days of receipt of a request from the board:
(a) All technician training records and evaluations;
(b) Program assessments conducted in accordance with this rule.
(7) Employer-based training programs may be subject to audit to ensure compliance with the requirements of this rule.
(a) An employer-based training program subject to audit shall provide all requested documentation demonstrating compliance with this rule within thirty days of a request by the board.
(b) Unless an extension is granted, failure to provide the requested documentation within thirty days of a request by the board may result in the suspension of the approval status of the training program.
(c) After reviewing the training program, the board may return it to the employer for revision. Failure to make the necessary revisions may result in the suspension of the approval status of the training program.
(d) The approval status of a training program may be reinstated only after the employer meets the requirements of this rule and any additional requirements as determined by the board.
(C) In order to perform non-sterile drug compounding, a pharmacy technician trainee shall complete the following training requirements prior to compounding non-sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing non-sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing non-sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this paragraph.
(6) Ensuring pharmacy technician trainees are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(8) The training required pursuant to this paragraph may be used to meet the practical experience hours required in paragraph (B)(2)(e) of this rule.
(D) In order to perform sterile drug compounding, a pharmacy technician trainee shall complete the following training requirements prior to compounding sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <797>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this paragraph.
(6) Ensuring pharmacy technician trainees are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(8) The training required pursuant to this paragraph may be used to meet the practical experience hours required in paragraph (B)(2)(e) of this rule.
(E) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of additional training that is of appropriate breadth and depth to clearly address the competencies for a technician trainee to safely and effectively work in a specific practice setting.
(F) Unless otherwise approved by the board, a board approved training program is only valid for application as a registered pharmacy technician or certified pharmacy technician in accordance with rule 4729:3-2-01 of the Administrative Code if the program was completed within five years of an application for registration.
(G) Paragraph (F) of this rule does not apply in the following circumstances:
(1) An applicant for registration has been actively practicing as a pharmacy technician in this or another state within one year of application to the board; or
(2) An applicant has maintained a current pharmacy technician certification from an organization that has been recognized by the board.
(H) An individual may sit for an examination to obtain a pharmacy technician certification from an organization that has been recognized by the board at any time.
Last updated March 7, 2024 at 7:44 AM
History
- Effective: March 7, 2024
- Promulgated Under: 119.03
Ohio Adm.Code 4729:5-4-01
(A) The state board of pharmacy, in accordance with Chapter 119. of the Revised Code, may impose any one or more of the following sanctions on a person licensed as a terminal distributor of dangerous drugs for any of the causes set forth in paragraph (B) of this rule:
(1) Suspend, revoke, restrict, limit, or refuse to grant or renew a license;
(2) Reprimand or place the license holder on probation;
(3) Impose a monetary penalty or forfeiture as set forth in section 4729.57 of the Revised Code.
(B) The board may impose the sanctions set forth in paragraph (A) of this rule for any of the following:
(1) Making any false material statements in an application for a license or renewal of a license as a terminal distributor of dangerous drugs.
(2) Violating any rule of the board.
(3) Violating any provision of Chapter 4729. of the Revised Code.
(4) Except as provided in section 4729.89 of the Revised Code, violating any provision of the "Federal Food, Drug, and Cosmetic Act," 52 Stat. 1040 (1938), 21 U.S.C.A. 301, or Chapter 3715. of the Revised Code.
(5) Violating any provision of the federal drug abuse control laws or Chapter 2925. or 3719. of the Revised Code.
(6) Falsely or fraudulently promoting to the public a dangerous drug, except that nothing in this rule prohibits a terminal distributor of dangerous drugs from furnishing information concerning a dangerous drug to a health care provider or another licensed terminal distributor.
(7) Ceasing to satisfy the qualifications of a terminal distributor of dangerous drugs set forth in section 4729.55 of the Revised Code.
(8) Except as provided in division (C) of section 4729.57 of the Revised Code:
(a) Waiving the payment of all or any part of a deductible or copayment that an individual, pursuant to a health insurance or health care policy, contract, or plan that covers the services provided by a terminal distributor of dangerous drugs, would otherwise be required to pay for the services if the waiver is used as an enticement to a patient or group of patients to receive pharmacy services from that terminal distributor;
(b) Advertising that the terminal distributor will waive the payment of all or any part of a deductible or copayment that an individual, pursuant to a health insurance or health care policy, contract, or plan that covers the pharmaceutical services, would otherwise be required to pay for the services.
(9) Conviction of a felony.
(10) Violation of any restrictions placed by the state board of pharmacy on a license or violating any terms of a board order issued against the licensee.
(11) Exclusion from participation in medicare or a state health care program.
(12) Being denied a license or registration by the drug enforcement administration or appropriate issuing body of any state or jurisdiction.
(13) Being the subject of any of the following by the drug enforcement administration or licensing agency of any state or jurisdiction:
(a) A disciplinary action that resulted in the suspension or revocation of the person's license or registration; or
(b) A disciplinary action that was based, in whole or in part, on the person's inappropriate prescribing, dispensing, diverting, administering, storing, personally furnishing, compounding, supplying or selling a controlled substance or other dangerous drug.
(14) Commission of an act that constitutes a disqualifying offense, regardless of the jurisdiction in which the act was committed.
(15) Has been subject to any of the following:
(a) A finding by a court of the person's eligibility for intervention in lieu of conviction; or
(b) A finding by a court of the person's eligibility for treatment or intervention in lieu of conviction in another jurisdiction.
(16) Has been granted entry into a diversion program, deferred prosecution program, or the equivalent thereof.
(17) Is addicted to or abusing alcohol or drugs.
(18) Commission of an act that constitutes a misdemeanor that is related to, or committed in, the person's professional practice.
(19) Employs a responsible person that does not meet the requirements set forth in rule 4729:5-2-01 of the Administrative Code.
(20) The ownership of such entity has been transferred from a person whose license issued in accordance with Chapter 4729. of the Revised Code has been revoked or disciplined by the state board of pharmacy or any other professional licensing agency to a spouse or other family member.
(21) The ownership of such facility has been transferred from a licensee whose license has been revoked or disciplined by the state board of pharmacy or any other professional licensing agency to another who employs the former owner or who allows the former owner to be present within the physical confines of the location to be licensed.
(22) Except as provided in Chapter 3719. of the Revised Code, dispensing a sample drug as defined in rule 4729:6-3-08 of the Administrative Code.
(23) The method used by the terminal distributor to store, possess or distribute dangerous drugs poses serious harm to others.
(24) The furnishing of false or fraudulent information or omitting information on due diligence questionnaires and/or attestation documents regarding the purchase or receipt of dangerous drugs from manufacturers, repackagers, third-party logistics providers, outsourcing facilities, wholesale distributors or other terminal distributors.
(25) Retaliating against or disciplining an employee for filing a complaint with a board of pharmacy or other licensing body or reporting a violation of state or federal statute or any ordinance or regulation of a political subdivision that the employee's employer has authority to correct. As used in this rule, retaliation or discipline of an employee includes, but is not limited to, the following:
(a) Removing or suspending the employee from employment;
(b) Withholding from the employee salary increases or employee benefits to which the employee is otherwise entitled;
(c) Transferring or reassigning the employee;
(d) Denying the employee a promotion that otherwise would have been received;
(e) Reducing the employee in pay or position.
(26) Unless otherwise approved by the board, a terminal distributor knowingly employs a person with access to drug stock who:
(a) Has been denied the right to work in any facility by the state board of pharmacy as part of an official order of the board.
(b) Has been denied the right to work in such a facility by another professional licensing agency as part of an official order of that agency.
(c) Has committed an act that constitutes a disqualifying offense, regardless of the jurisdiction in which the act was committed.
(d) Has committed an act that constitutes a misdemeanor or felony drug offense, except for a minor misdemeanor drug offense, regardless of the jurisdiction in which the act was committed.
(e) Has been subject to any of the following:
(i) A finding by a court of the person's eligibility for intervention in lieu of conviction; or
(ii) A finding by a court of the person's eligibility for treatment or intervention in lieu of conviction in another jurisdiction.
(f) Has been granted entry into a diversion program, deferred prosecution program, or the equivalent thereof.
(g) Is addicted to or abusing alcohol or drugs.
(h) Has been excluded from participation in medicare or a state health care program.
(i) Has been denied a license or registration by the drug enforcement administration or appropriate issuing body of any state or jurisdiction.
(j) Has been the subject of any of the following by the drug enforcement administration or licensing agency of any state or jurisdiction:
(i) A disciplinary action that resulted in the suspension, probation, surrender or revocation of the person's license or registration; or
(ii) A disciplinary action that was based, in whole or in part, on the person's inappropriate prescribing, dispensing, diverting, administering, storing, securing, personally furnishing, compounding, supplying or selling a controlled substance or other dangerous drug.
(k) Has committed an act that constitutes a misdemeanor that is related to, or committed in, the employee's professional practice.
Last updated July 1, 2026 at 12:19 PM
History
- Effective: April 25, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:5-6-03
(A) A terminal distributor of dangerous drugs engaged in the preparation, compounding, dispensing, or repackaging of radiopharmaceuticals for humans and animals shall comply with USP <825>.
(B) All radiopharmaceuticals shall be dispensed pursuant to a patient-specific prescription issued by a licensed health professional authorized to prescribe drugs.
(1) A limited quantity may be prepared and distributed in anticipation of prescriptions based on routine, regularly observed prescribing patterns.
(2) In the event a patient's name is not available at the time of dispensing, a nuclear pharmacy shall have up to seventy-two hours to obtain the name of the patient. No later than seventy-two hours after dispensing the radiopharmaceutical, the patient's name must be associated with the prescription in the dispensing records maintained in accordance with rule 4729:5-6-04 of the Administrative Code.
(C) All radiopharmaceuticals are exempt from the labeling requirements of division 4729:5 of the Administrative Code.
(1) Radiopharmaceuticals shall be labeled in accordance with USP <825>.
(2) In addition to the requirements in paragraph (C)(1) of this rule, the outer shielding shall also be labeled with the following:
(a) The name and telephone number of the pharmacy;
(b) The prescription number; and
(c) The patient's name (first name and last name or first initial and last name), if available at the time of dispensing.
(3) In addition to the requirements in paragraph (C)(1) of this rule, the immediate container shall also be labeled with the following information:
(a) The prescription number; and
(b) The patient's name (first name and last name or first initial and last name), if available at the time of dispensing.
(D) A terminal distributor shall ensure that all employees comply with all applicable local, state, and federal requirements for the proper labeling, environmental controls, integrity, and safety of all products transported.
(E) A terminal distributor shall ensure that all employees comply with all applicable local, state, and federal requirements for the disposal of radioactive and/or biohazardous waste in a manner so as not to endanger the health and safety of the public.
(F) All personnel trained to work with radiopharmaceuticals shall do so under the personal supervision of an authorized nuclear pharmacist.
(G) A terminal distributor shall report any event as a medical event, except for an event that results from patient intervention, to the Ohio department of health in accordance with rule 3701:1-58-101 of the Administrative Code.
Last updated February 2, 2022 at 10:10 AM
History
- Effective: February 1, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:5-6-01
As used in Chapter 4729:5-6 of the Administrative Code:
(A) "Radiopharmaceutical," "radiopharmaceutical preparation," or "radioactive drug" means a finished dosage form of a dangerous drug that contains a radioactive substance in association with one or more other ingredients and that is intended to diagnose, stage a disease, monitor treatment, or provide therapy. A radiopharmaceutical includes any nonradioactive reagent kit or radionuclide generator that is intended to be used in the preparation of any such substance. The terms "radiopharmaceutical" and "radioactive drug" are commonly used interchangeably.
(B) "Authorized nuclear pharmacist" means a licensed pharmacist that meets the requirements in rule 3701:1-58-20 of the Administrative Code.
(C) "Beyond-use date" means the assigned date and time beyond which the radiopharmaceutical must not be administered.
(D) "Compounding" has the same meaning as in USP <825>.
(E) "Dangerous drug" has the same meaning as in section 4729.01 of the Revised Code.
(F) "Dispense" means the final association of a drug with a particular patient pursuant to a prescription, drug order, or other lawful order of a prescriber and the professional judgment of and the responsibility for interpreting, preparing, compounding, labeling, and packaging a specific drug.
(G) "Final check" means the final verification check for accuracy and conformity to the formula of the compounded preparation or product being prepared, correct ingredients and calculations, accurate and precise measurements, appropriate conditions and procedures, and appearance of the final product.
(H) "Kit" means a commercially manufactured package containing all ingredients required to prepare a radiopharmaceutical with the exception of the radionuclide.
(I) "Licensed health professional authorized to prescribe drugs" or "prescriber" has the same meaning as in rule 4729:5-1-02 of the Administrative Code but shall be limited to a prescriber practicing within the prescriber's applicable scope of practice.
(J) "Non-sterile compounded drug" means a dangerous drug preparation intended to be nonsterile.
(K) "Nuclear pharmacy" is a pharmacy licensed as a terminal distributor of dangerous drugs where prescriptions for radiopharmaceuticals are prepared, compounded, dispensed, or repackaged. A nuclear pharmacy shall also be licensed by the United States nuclear regulatory commission or the appropriate state nuclear regulatory agency.
(L) "Personal supervision" means the person specified in rule shall be physically present at the licensed location to provide personal review and approval of all professional activities.
(M)
(1) "Positive identification" means a method of identifying a person that does not rely on the use of a private personal identifier such as a password, but must use a secure means of identification such as the following:
(a) A manual signature on a hard copy record;
(b) A magnetic card reader;
(c) A bar code reader;
(d) A biometric method;
(e) A proximity badge reader;
(f) A board approved system of randomly generated personal questions;
(g) A printout of every transaction that is verified and manually signed within a reasonable period of time by the individual who prescribed, administered, or dispensed the dangerous drug. The printout must be maintained for three years and made readily retrievable; or
(h) Other effective methods for identifying individuals that have been approved by the board.
(2) A method relying on a magnetic card reader, a bar code reader, a proximity badge reader, or randomly generated questions for identification must also include a private personal identifier, such as a password, for entry into a secure mechanical or electronic system.
(N) "Preparing" or "preparation" means the act of combining a conventionally manufactured kit with a conventionally manufactured radionuclide following manufacturer's recommended instructions. Mixing, reconstituting, combining, diluting, or repackaging of a radiopharmaceutical, or other such acts, performed in accordance with directions contained in the FDA-approved labeling.
(O) "Preparation with minor deviation" means the act of preparing conventionally manufactured radionuclide with volume, and/or radioactivity, and/or step-by-step deviations from the manufactures recommended labeling while ensuring that the final preparation maintains appropriate radiochemical and radionuclidic purity for the entirety of the beyond-use date.
(P) "Product" means a drug in a commercially manufactured pharmaceutical dosage form that has been evaluated for safety and efficacy by the United States food and drug administration. Products are accompanied by full prescribing information, which is commonly known as the United States food and drug administration-approved manufacturer's labeling or product package insert.
(Q) "Readily retrievable" means that records maintained in accordance with this chapter shall be kept in such a manner that, upon request, they can be produced for review no later than three business days to an agent, officer or inspector of the board.
(R) "Responsible person" has the same meaning as defined in rule 4729:5-2-01 of the Administrative Code and is responsible for the supervision and control of dangerous drugs as required in division (B) of section 4729.55 of the Revised Code, adequate safeguards as required in division (C) of section 4729.55 of the Revised Code, security and control of dangerous drugs, and maintaining all drug records otherwise required.
(1) Except as provided in paragraph (R)(2) of this rule, a nuclear pharmacy shall have an authorized nuclear pharmacist as its responsible person. Responsible person shall also mean the "designated person" as used in USP 825.
(2) An institutional facility licensed as a terminal distributor of dangerous drugs with an on-site nuclear pharmacy that is engaged in the preparation, preparation with minor deviation, compounding, dispensing, or repackaging of radiopharmaceuticals shall comply with the following:
(a) Submit notification to the board, in a manner determined by the board, that the facility is engaged in the preparation, preparation with minor deviation, compounding, dispensing, or repackaging of radiopharmaceuticals.
(i) For new facilities, the institutional facility shall notify the board within ten days of the date the facility engages in the preparation, preparation with minor deviation, compounding, dispensing, or repackaging of radiopharmaceuticals.
(ii) For existing facilities, the institutional facility shall notify the board within ten days of the effective date of this rule.
(b) A nuclear pharmacy that ceases to engage in the preparation, preparation with minor deviation, compounding, dispensing, or repackaging of radiopharmaceuticals shall submit notification to the board, in a manner determined by the board, within ten days of cessation.
(c) The facility shall have a designated person who is an authorized nuclear pharmacist employed by the facility that is responsible and accountable for the performance and operation of the radiopharmaceutical processing facility and for personnel who prepare, prepare with minor deviation, compound, dispense, personally furnish, and repackage radiopharmaceuticals.
(i) For new facilities, the institutional facility shall notify the board of the designated person within ten days of the date the nuclear pharmacy in a facility engages in the preparation, preparation with minor deviation, compounding, dispensing, personally furnishing, or repackaging of radiopharmaceuticals.
(ii) For existing facilities, the institutional facility shall notify the board of the designated person within ten days of the effective date of this rule.
(iii) If there is a change in the designated person, the board shall be notified within ten days of the effective date of the appointment of the new designated person.
(S) "Sterile" means a dosage form free of living microorganisms (aseptic).
(T) "Sterile compounded drug" means a dangerous drug preparation intended to be sterile.
(U) "United States Pharmacopeia Chapter <825>" or "USP <825>" means United States Pharmacopeia Chapter <825>, USP 42-NF 37 2S, or any official supplement thereto (12/1/2020).
Last updated February 2, 2022 at 10:10 AM
History
- Effective: February 1, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-2-01
(A) An applicant for registration as a pharmacy technician trainee shall:
(1) Comply with all requirements set forth in section 4729.92 of the Revised Code.
(2) Comply with the criminal records check requirements pursuant to rule 4729:3-2-02 of the Administrative Code.
(3) Submit a complete application for registration, in a manner determined by the board, that includes:
(a) The required application fee established in section 4729.921 of the Revised Code, including any transaction fee as required by section 125.18 of the Revised Code.
(b) Except as provided in paragraph (A)(3)(c) of this rule, documentation, as specified by the board, that the applicant meets both of the following requirements:
(i) Has a high school diploma, a certificate of high school equivalence, a foreign school diploma that is equivalent to a U.S. high school diploma or has been employed continuously since prior to April 8, 2009, as a pharmacy technician without a high school diploma or certificate of high school equivalence; and
(ii) Is at least seventeen years of age.
(c) Notwithstanding the requirements of paragraph (A)(3)(b) of this rule, the board may register as a pharmacy technician trainee an applicant who is seventeen or eighteen years of age and does not possess a high school diploma or certificate of high school equivalence if the applicant is enrolled in a career-technical school program that is approved by the board and conducted by a city, exempted village, local, or joint vocational school district.
(d) Any additional information or documentation as determined by the board.
(4) A pharmacy technician trainee licensed or registered in another state may apply for registration by reciprocity by complying with the requirements listed in paragraphs (A)(1) to (A)(3) of this rule.
(B) An applicant for registration as a registered pharmacy technician shall:
(1) Comply with all requirements set forth in section 4729.90 of the Revised Code.
(2) Comply with either of the following:
(a) Have completed an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code; or
(b) Hold a pharmacy technician registration or license issued by another state and have actively worked as a pharmacy technician for at least one year within the previous five years of application.
(3) Comply with the criminal records check requirements pursuant to rule 4729:3-2-02 of the Administrative Code.
(4) Submit a complete application for registration, in a manner determined by the board, that includes:
(a) The required application fee established in section 4729.901 of the Revised Code, including any transaction fee as required by section 125.18 of the Revised Code;
(b) Except for applicants currently registered as pharmacy technician trainees, documentation, as specified by the board, that the applicant meets the following requirements:
(i) Has a high school diploma, a certificate of high school equivalence, a foreign school diploma that is equivalent to a U.S. high school diploma or has been employed continuously since prior to April 8, 2009, as a pharmacy technician without a high school diploma or certificate of high school equivalence;
(ii) Is at least eighteen years of age; and
(iii) If the applicant has a foreign school diploma that is equivalent to a U.S. high school diploma, the applicant shall submit evidence of successful completion of the "Test of English as a Foreign Language, Internet-based test" (TOEFL iBT) pursuant to rule 4729:3-2-05 of the Administrative Code.
(c) Paragraph (B)(4)(b)(iii) of this rule shall not apply if the applicant complies with any of the following:
(i) Submits a diploma or transcript demonstrating completion of an associate degree or higher from an accredited college, junior college, community college, or university in the United States.
(ii) Submits verification of active professional license or registration issued under the following chapters of the Revised Code: 4715., 4723., 4725., 4729., 4730., 4731., 4732., 4734., 4741., 4744., 4753., 4755., 4757., 4759., 4760., 4761., 4762., 4774., 4778., 4779., 4783.
(iii) Submits verification of an active professional license or registration from another state that permits the applicant to engage in the same profession, occupation, or occupational activity as any license or registration issued by an agency listed in paragraph (B)(4)(c)(ii) of this rule.
(iv) Submits an attestation signed by the responsible person, or the equivalent in the state where the technician is registered, of the pharmacy where the technician is actively employed or was employed in the five years prior to the date of submission of an application. The responsible person must complete the required attestation form provided by the board and attest to their personal observation that the technician applicant demonstrates the required proficiency (reading, listening, speaking, and writing) in the English language to practice safely and effectively as a registered pharmacy technician.
(v) Submits documentation of any other board approved method for demonstrating English language proficiency.
(d) Any of the following documentation:
(i) An attestation, certificate of completion, or other board approved documentation that the applicant has successfully completed an approved training program in accordance with rule 4729:3-3-02 of the Administrative Code.
(ii) Documentation, as determined by the board, demonstrating compliance with the reciprocity requirements of paragraph (B)(2)(b) of this rule.
(e) Any additional information or documentation as determined by the board.
(C) An applicant for registration as a certified pharmacy technician shall:
(1) Comply with all requirements set forth in section 4729.90 of the Revised Code.
(2) Comply with either of the following:
(a) Have completed an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code;
(b) Hold a pharmacy technician registration or license issued by another state and have actively worked as a pharmacy technician for at least one year within the previous five years of application; or
(c) Holds a current pharmacy technician certification from an organization that has been recognized by the board for at least two years immediately preceding the date the application is submitted and has been actively practicing as a pharmacy technician in a state that does not issue a pharmacy technician license or registration for at least two of the five years immediately preceding the date the application is submitted.
(3) Comply with the criminal records check requirements pursuant to rule 4729:3-2-02 of the Administrative Code.
(4) Submit a complete application for registration, in a manner determined by the board, that includes:
(a) The required application fee established in section 4729.901 of the Revised Code, including any transaction fee as required by section 125.18 of the Revised Code, except as provided in rule 4729:3-2-03 of the Administrative Code;
(b) Documentation, as specified by the board, that the applicant has a current pharmacy technician certification from an organization that has been recognized by the board.
(c) Except for applicants currently registered as pharmacy technician trainees, documentation, as specified by the board, that the applicant meets the following requirements:
(i) Has a high school diploma, a certificate of high school equivalence or a foreign school diploma that is equivalent to a U.S. high school diploma;
(ii) Is at least eighteen years of age; and
(iii) If the applicant has a foreign school diploma that is equivalent to a U.S. high school diploma, the applicant shall submit evidence of successful completion of the "Test of English as a Foreign Language, Internet-based test" (TOEFL iBT) pursuant to rule 4729:3-2-05 of the Administrative Code.
(d) Paragraph (C)(4)(c)(iii) of this rule shall not apply if the applicant complies with either of the following:
(i) Submits a diploma or transcript demonstrating completion of an associate degree or higher from an accredited college, junior college, community college or university in the United States.
(ii) Submits verification of active professional license or registration issued under the following chapters of the Revised Code: 4715., 4723., 4725., 4729., 4730., 4731., 4732., 4734., 4741., 4744., 4753., 4755., 4757., 4759., 4760., 4761., 4762., 4774., 4778., 4779., 4783.
(iii) Submits verification of an active professional license or registration from another state that permits the applicant to engage in the same profession, occupation, or occupational activity as any license or registration issued by an agency listed in paragraph (C)(4)(d)(ii) of this rule.
(iv) Submits an attestation signed by the responsible person, or the equivalent in the state where the technician is registered, of the pharmacy where the technician is actively employed or was employed in the five years prior to the date of submission of an application. The responsible person must complete the required attestation form provided by the board and attest to their personal observation that the technician applicant demonstrates the required proficiency (reading, listening, speaking, and writing) in the English language to practice safely and effectively as a certified pharmacy technician.
(v) Submits documentation of any other board approved method for demonstrating English language proficiency.
(e) Any of the following documentation:
(i) An attestation, certificate of completion, or other board approved documentation that the applicant has successfully completed an approved training program in accordance rule 4729:3-3-02 of the Administrative Code.
(ii) Documentation, as determined by the board, demonstrating compliance with the reciprocity requirements of paragraphs (C)(2)(b) and (C)(2)(c) of this rule.
(f) Any additional information or documentation as determined by the board.
(D) Pursuant to section 4729.921 of the Revised Code, a registration for a pharmacy technician trainee is valid for eighteen months from the date of issuance.
(E) A pharmacy technician trainee that fails to meet the education and training requirements during the trainee's initial registration period, may apply for reinstatement of their registration by submitting an application and fee as required by paragraph (A) of this rule. Only one reinstatement shall be granted, but an individual may reapply for registration if the individual's previous registration has lapsed for more than five years or the board grants its approval.
(F) Pursuant to section 4729.96 of the Revised Code, a limited or restricted registration may be issued to an applicant upon the determination of the board.
(G) An initial registration for a registered pharmacy technician and certified pharmacy technician is valid until the renewal date set forth in rule 4729:3-2-03 of the Administrative Code.
(H) Failure to complete all application requirements within thirty days after being notified by the board may result in the application being deemed abandoned as defined in rule 4729:3-1-01 of the Administrative Code.
(I) Registration fees for veterans shall be waived upon submission of the appropriate documentation. Documentation required to obtain a fee waiver will be published on the state board of pharmacy's web site: www.pharmacy.ohio.gov.
Last updated May 15, 2026 at 7:34 AM
History
- Effective: May 15, 2026
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-03 Registered pharmacy technicians.
(A) A registered pharmacy technician shall wear a name tag or badge which contains the designation "Registered Pharmacy Technician." The required designation may be added to an existing name tag or badge. The name tag or badge and the required designation shall contain lettering of a legible size.
(B) A registered pharmacy technician may, under the direct supervision of a pharmacist, engage in the following activities at a location licensed as a terminal distributor of dangerous drugs to the extent that the activities do not require the exercise of professional judgment:
(1) Accepting new written, faxed or electronic prescription orders from a prescriber or a prescriber's agent but shall not include verbal orders;
(2) Requesting refill authorizations for dangerous drugs from a prescriber or prescriber's agent, so long as there is no change from the original prescription;
(3) Entering information into and retrieving information from a database or patient profile;
(4) Preparing and affixing labels;
(5) Stocking dangerous drugs and retrieving those drugs from inventory;
(6) Counting and pouring dangerous drugs into containers;
(7) Placing dangerous drugs into containers prior to dispensing by a pharmacist;
(8) Non-sterile drug compounding in accordance with the required training in paragraph (D) of this rule;
(9) Sterile drug compounding in accordance with the required training in paragraph (E) of this rule;
(10) Packaging and selling a dangerous drug to a patient or patient representative;
(11) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner;
(12) Stocking automated drug storage systems, floor stock, and crash carts at a location licensed as a terminal distributor of dangerous drugs if either of the following applies:
(a) The terminal distributor utilizes barcode administration for restocking the drugs and develops and implements a quality assurance program to ensure the accuracy of the personnel stocking the dangerous drugs; or
(b) For restocking automated drug storage systems only: a pharmacist verifies the final dispensing of a dangerous drug removed from the automated drug storage system.
(C) A registered pharmacy technician may:
(1) Engage in remote entry of prescriptions in accordance rule 4729:5-5-25 of the Administrative Code; or
(2) Engage in remote entry of medication orders in accordance with rule 4729:5-9-02.15 of the Administrative Code.
(D) In order to perform non-sterile drug compounding, a registered pharmacy technician shall complete the following training requirements prior to compounding non-sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing non-sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing non-sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(6) Ensuring registered pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(E) In order to perform sterile drug compounding, a registered pharmacy technician shall complete the following training requirements prior to compounding sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <797>, as defined in rule 4729:7-1-01 of the Administrative Code.
(2) If preparing sterile hazardous compounded drugs in accordance with rule 4729:7-2-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <800>, as defined in rule 4729:7-1-01 of the Administrative Code.
(3) If preparing sterile radiopharmaceuticals in accordance with rule 4729:5-6-03 of the Administrative Code, the training shall also comply with the applicable requirements set forth in United States pharmacopeia chapter <825>, as defined in rule 4729:5-6-01 of the Administrative Code.
(4) Sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(5) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible persons designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(6) Ensuring registered pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(7) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(F) A registered pharmacy technician shall be permitted to perform sterile compounding in accordance with this rule if all the following apply:
(1) The registered pharmacy technician is in the process of studying to obtain technician certification from an organization that has been recognized by the board;
(2) The registered pharmacy technician shall not engage in sterile drug compounding at the location licensed as a terminal distributor of dangerous drugs for longer than eighteen months from the date the technician completed the required sterile compounding training in paragraph (E) of this rule.
(3) A terminal distributor of dangerous drugs that permits a registered pharmacy technician to engage in sterile drug compounding shall develop and implement a process to ensure the registered pharmacy technician does not exceed the time limitation established in paragraph (F)(2) of this rule. The terminal distributor of dangerous drugs shall be accountable for a registered technician found to be in violation of this paragraph.
(G) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of policies and procedures for additional training appropriate to duties and responsibilities performed by a registered pharmacy technician as well as an ongoing quality assurance plan to ensure competency.
Last updated March 7, 2024 at 7:45 AM
History
- Effective: March 7, 2024
- Promulgated Under: 119.03
Ohio Adm.Code 4729:5-5-25
(A) As used in this rule:
(1) "Direct supervision" and "personal supervision" have the same meaning as in rule 4729:3-1-01 of the Administrative Code.
(2) "Remote prescription entry" means the entry of prescriptions for an outpatient pharmacy licensed as a terminal distributor of dangerous drugs by a remote technician under the direct supervision or remote supervision of a pharmacist. Remote prescription entry does not include dispensing, interpreting, evaluating, or approval of prescriptions or any other activities not permitted by state or federal laws, rules, and regulations. Remote prescription entry may include clarifying prescriptions and other data entry, including the processing of insurance coverage. The requirements of this rule shall be limited to the entry of prescriptions dispensed in or into this state.
(3) "Remote pharmacy" means either:
(a) A pharmacy licensed as a terminal distributor of dangerous drugs that dispenses dangerous drugs; or
(b) A pharmacy licensed as a limited category II terminal distributor of dangerous drugs which does not stock, own, or dispense any dangerous drugs, and whose sole business consists of entry, review, and/or verification of prescriber orders and consulting services under contract for outpatient pharmacies in this state.
(4) "Remote supervision" means that a pharmacist directs and controls the actions of remote technicians through the use of technology that ensures a supervising pharmacist can meet the requirements listed in this paragraph. A pharmacist providing remote supervision shall:
(a) Be readily available to answer questions of a remote technician; and
(b) Be fully responsible for the practice and accuracy of the remote technician.
(5) "Remote technician" means any of the following:
(a) If performing remote prescription entry in this state: an Ohio registered certified pharmacy technician, registered pharmacy technician, or pharmacy technician trainee, either employed or a contract employee of an outpatient pharmacy or remote pharmacy, who either conducts prescription entry from a remote site, which may include the technician's residence or other location where the technician and the outpatient or remote pharmacy can ensure the confidentiality and integrity of patient information, or on the premises of a remote pharmacy or outpatient pharmacy; or
(b) If performing remote prescription entry outside of this state: a pharmacy technician who meets the following criteria:
(i) The pharmacy technician is licensed or registered in the state where the remote prescription entry is occurring, or if working in a state that has not yet implemented a technician registration process, has received training and is working as a pharmacy technician in accordance with of the laws and regulations of their state of practice; and
(ii) The pharmacy technician is either employed or a contract employee of an outpatient pharmacy or remote pharmacy who holds a nonresident pharmacy license in accordance with Chapter 4729:5-8 of the Administrative Code, who either conducts prescription entry from a remote site, which may include the technician's residence or other location where the technician and the outpatient or remote pharmacy can ensure the confidentiality and integrity of patient information, or on the premises of a remote pharmacy or outpatient pharmacy.
(c) A nonresident pharmacy shall be responsible for ensuring all actions performed by an unregistered technician comply with the applicable requirements for conducting remote prescription entry.
(d) A remote technician shall only be permitted to conduct remote prescription entry within the United States, to include the District of Columbia, the Commonwealth of Puerto Rico or a territory or insular possession subject to the jurisdiction of the United States.
(B) An outpatient pharmacy may outsource prescription entry to a remote pharmacy provided the pharmacies are under common ownership or control or the outpatient pharmacy has entered into a written contract or agreement with a pharmacy that outlines the services to be provided and the responsibilities and accountabilities of each party to the contract or agreement in compliance with federal and state statutes and regulations.
(C) The outpatient pharmacy and remote pharmacy must maintain a copy of the contract or agreement in a readily retrievable manner for inspection and review by an agent, inspector, or employee of the board.
(D) An outpatient pharmacy utilizing remote prescription entry shall ensure that all remote technicians providing such services have been trained on the outpatient pharmacy's policies and procedures relating to prescription entry.
(1) The training of each remote technician shall be documented. The outpatient pharmacy and the remote pharmacy shall jointly develop a procedure to communicate changes in policies and procedures related to prescription entry.
(2) A terminal distributor of dangerous drugs may utilize one training program for all outpatient pharmacies under the terminal distributor's common ownership and control.
(E) An outpatient pharmacy utilizing remote technicians shall maintain or have access to a record of the name and address of each technician, evidence of current licensure or registration, and the address of each location where the technician will be providing remote prescription entry services.
(F) The outpatient pharmacy shall ensure that any remote technician shall have secure electronic access to the outpatient pharmacy's patient information system and to other electronic systems that an on-site technician has access to when the pharmacy is open.
(G) Each remote entry record must comply with all recordkeeping requirements for outpatient pharmacies, including capturing the positive identification of the remote technician involved in the entry of the prescription.
(H) An outpatient pharmacy utilizing remote prescription entry is responsible for maintaining records of all prescriptions entered into their information system, including prescriptions entered by a remote technician.
(I) An outpatient pharmacy utilizing remote prescription entry services shall develop and implement a policy and procedure manual. A remote pharmacy shall maintain a copy of those portions of the policy and procedure manual that relate to the remote pharmacy's operations. Each manual shall include all the following:
(1) An overview of the responsibilities of the outpatient pharmacy and the remote pharmacy;
(2) A list of the names, addresses, telephone numbers, and all license numbers of the pharmacies and remote technicians involved in remote prescription entry; and
(3) Policies and procedures for:
(a) Protecting the confidentiality and integrity of patient information;
(b) Ensuring that no patient information is duplicated, downloaded, or removed from the outpatient pharmacy's patient information system;
(c) Maintaining appropriate records of each technician involved in prescription entry;
(d) Complying with federal and state statutes and regulations; and
(e) Reviewing written policies and procedures at least every three years or upon the implementation of a significant change of written policies and procedures and documentation of the review.
(J) A pharmacy intern that is licensed in this or any other state may engage in remote prescription entry pursuant to the requirements of this rule.
Last updated November 30, 2021 at 8:28 AM
History
- Effective: November 30, 2021
- Promulgated Under: 119.03
Ohio Adm.Code 4729:5-9-02.15
(A) As used in this rule:
(1) "Direct supervision" and "personal supervision" have the same meaning as in rule 4729:3-1-01 of the Administrative Code.
(2) "Remote order entry" means the entry of medication orders for an inpatient pharmacy licensed as a terminal distributor of dangerous drugs by a remote technician under the direct supervision or remote supervision of a pharmacist. Remote order entry does not include dispensing, interpreting, evaluating, or approval of medication orders or any other activities not permitted by state or federal laws, rules, and regulations. Remote order entry may include clarifying orders and other data entry, including the processing of insurance coverage. The requirements of this rule shall be limited to the entry of orders dispensed in or into this state.
(3) "Remote pharmacy" means either:
(a) A pharmacy licensed as a terminal distributor of dangerous drugs that dispenses dangerous drugs; or
(b) A pharmacy licensed as a limited category II terminal distributor of dangerous drugs which does not stock, own, or dispense any dangerous drugs, and whose sole business consists of entry, review, and/or verification of prescriber orders and consulting services under contract for institutional pharmacies in this state.
(4) "Remote supervision" means that a pharmacist directs and controls the actions of remote technicians through the use of technology that ensures a supervising pharmacist can meet the requirements listed in this paragraph. A pharmacist providing remote supervision shall:
(a) Be readily available to answer questions of a remote technician; and
(b) Be fully responsible for the practice and accuracy of the remote technician.
(5) "Remote technician" means any of the following:
(a) If performing remote order entry in this state: an Ohio registered certified pharmacy technician, registered pharmacy technician, or pharmacy technician trainee, either employed or a contract employee of an inpatient pharmacy or remote pharmacy, who either conducts order entry from a remote site, which may include the technician's residence or other location where the technician and the outpatient or remote pharmacy can ensure the confidentiality and integrity of patient information, or on the premises of a remote pharmacy or institutional pharmacy; or
(b) If performing remote order entry outside of this state: a pharmacy technician who meets the following criteria:
(i) The pharmacy technician licensed or registered in the state where the remote order entry is occurring, or if working in a state that has not yet implemented a technician registration process, has received training and is working as a pharmacy technician in accordance with of the laws and regulations of their state of practice; and
(ii) The pharmacy technician is either employed or a contract employee of an institutional pharmacy or remote pharmacy who holds a nonresident pharmacy license in accordance with Chapter 4729:5-8 of the Administrative Code, who either conducts order entry from a remote site, which may include the technician's residence or other location where the technician and the outpatient or remote pharmacy can ensure the confidentiality and integrity of patient information, or on the premises of a remote pharmacy or institutional pharmacy.
(c) A nonresident pharmacy shall be responsible for ensuring all actions performed by an unregistered technician comply with the applicable requirements for conducting remote order entry.
(d) A remote technician shall only be permitted to conduct remote order entry within the United States, to include the District of Columbia, the Commonwealth of Puerto Rico or a territory or insular possession subject to the jurisdiction of the United States.
(B) An institutional pharmacy may outsource order entry to a remote pharmacy provided the pharmacies are under common ownership or control or the institutional pharmacy has entered into a written contract or agreement with a pharmacy that outlines the services to be provided and the responsibilities and accountabilities of each party to the contract or agreement in compliance with federal and state statutes and regulations.
(C) The inpatient pharmacy and remote pharmacy must maintain a copy of the contract or agreement in a readily retrievable manner for inspection and review by an agent, inspector, or employee of the board.
(D) An inpatient pharmacy utilizing remote order entry shall ensure that all remote technicians providing such services have been trained on the inpatient pharmacy's policies and procedures relating to order entry.
(1) The training of each remote technician shall be documented. The inpatient pharmacy and the remote pharmacy shall jointly develop a procedure to communicate changes in policies and procedures related to order entry.
(2) A terminal distributor of dangerous drugs may utilize one training program for all inpatient pharmacies under the terminal distributor's common ownership and control.
(E) An inpatient pharmacy utilizing remote technicians shall maintain or have access to a record of the name and address of each technician, evidence of current licensure or registration, and the address of each location where the technician will be providing remote order entry services.
(F) The inpatient pharmacy shall ensure that any remote technician shall have secure electronic access to the inpatient pharmacy's patient information system and to other electronic systems that an on-site technician has access to when the pharmacy is open.
(G) Each remote entry record must comply with all recordkeeping requirements for inpatient pharmacies, including capturing the positive identification of the remote technician involved in the entry of the medication order.
(H) An inpatient pharmacy utilizing remote order entry is responsible for maintaining records of all orders entered into their information system, including orders entered by a remote technician.
(I) An inpatient pharmacy utilizing remote order entry services shall develop and implement a policy and procedure manual. A remote pharmacy shall maintain a copy of those portions of the policy and procedure manual that relate to the remote pharmacy's operations. Each manual shall include all the following:
(1) An overview of the responsibilities of the inpatient pharmacy and the remote pharmacy;
(2) A list of the names, addresses, telephone numbers, and all license numbers of the pharmacies and remote technicians involved in remote order entry; and
(3) Policies and procedures for:
(a) Protecting the confidentiality and integrity of patient information;
(b) Ensuring that no patient information is duplicated, downloaded, or removed from the inpatient pharmacy's patient information system;
(c) Maintaining appropriate records of each technician involved in order entry;
(d) Complying with federal and state statutes and regulations; and
(e) Reviewing written policies and procedures at least every three years or upon the implementation of a significant change of written policies and procedures and documentation of the review.
(J) A pharmacy intern that is licensed in this or any other state may engage in remote order entry pursuant to the requirements of this rule.
Last updated November 30, 2021 at 8:29 AM
History
- Effective: November 30, 2021
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-04 Certified pharmacy technicians.
(A) As used in this rule, "positive identification" has the same meaning as in rule 4729:5-5-01 of the Administrative Code.
(B) A certified pharmacy technician shall wear a name tag or badge which contains the designation "Certified Pharmacy Technician." The required designation may be added to an existing name tag or badge. The name tag or badge and the required designation shall contain lettering of a legible size.
(C) A certified pharmacy technician may, under the direct supervision of a pharmacist, engage in the following activities at a location licensed as a terminal distributor of dangerous drugs to the extent that the activities do not require the exercise of professional judgment:
(1) Accepting new written, faxed or electronic prescription orders from a prescriber or a prescriber's agent. New verbal prescription orders from a prescriber or a prescriber's agent for non-controlled drugs may be accepted pursuant to paragraph (C)(13) of this rule.
(2) Entering information into and retrieving information from a database or patient profile.
(3) Preparing and affixing labels.
(4) Stocking dangerous drugs and retrieving those drugs from inventory.
(5) Counting and pouring dangerous drugs into containers.
(6) Placing dangerous drugs into containers prior to dispensing by a pharmacist.
(7) Non-sterile drug compounding in accordance with the required training in paragraph (D) of this rule.
(8) Sterile drug compounding in accordance with the required training in paragraph (E) of this rule.
(9) Packaging and selling a dangerous drug to a patient or patient representative.
(10) Sending or receiving electronic prescriptions between pharmacies accessing the same prescription records in a centralized database or pharmacy computers linked in any other manner.
(11) Stocking automated drug storage systems, floor stock, and crash carts at a location licensed as a terminal distributor of dangerous drugs.
(a) Notwithstanding the definition of direct supervision in rule 4729:3-1-01 of the Administrative Code, a certified pharmacy technician may stock automated drug storage systems, crash carts, and floor stock at a location licensed as a terminal distributor of dangerous drugs if a pharmacist is not physically present at the licensed location and all of the following apply:
(i) A pharmacist is readily available to answer questions of the certified pharmacy technician;
(ii) A pharmacist is responsible for conducting routine verifications of the activities of the certified pharmacy technician to prevent the diversion of dangerous drugs;
(iii) A pharmacist is fully responsible for all activities conducted by the certified pharmacy technician at the licensed location.
(12) Requesting refill authorizations for dangerous drugs from a prescriber or prescriber's agent, so long as there is no change from the original prescription;
(13) Accepting new verbal prescription orders, including refill authorizations, for non-controlled drugs from a prescriber or a prescriber's agent pursuant to all of the following:
(a) The pharmacist on duty who is supervising the activity of the certified pharmacy technician will determine if the technician is competent to receive a verbal order.
(b) The pharmacist on duty who is supervising the activity of the certified pharmacy technician is responsible for the accuracy of a prescription order received by a technician.
(c) The pharmacist on duty must be immediately available to answer questions or discuss the prescription order received by a certified pharmacy technician.
(d) The certified pharmacy technician may not receive a prescription order for a controlled substance.
(e) If applicable, the certified pharmacy technician receiving a prescription order must document the full name of the prescriber's agent.
(f) The receiving certified pharmacy technician shall immediately reduce the prescription order to writing, which may include entering the information directly into a computerized record keeping system, and shall review the prescription with the pharmacist on duty.
(g) Prior to dispensing, positive identification of the receiving certified pharmacy technician and the pharmacist on duty shall be recorded to identify the responsibility for the receipt of the prescription.
(h) The certified pharmacy technician and the pharmacist on duty must meet all other applicable rules for the receipt of new verbal prescription orders pursuant to agency 4729 of the Administrative Code.
(14) Send or receive copies of non-controlled prescriptions pursuant to all of the following:
(a) The pharmacist on duty who is supervising the activity of the certified pharmacy technician will determine if the technician is competent to send or receive a prescription copy.
(b) The pharmacist on duty who is supervising the activity of the certified pharmacy technician is responsible for the accuracy of a prescription copy that is sent or received by a technician.
(c) The pharmacist on duty must be immediately available to answer questions or discuss the prescription copy that is sent or received by a certified pharmacy technician.
(d) The certified pharmacy technician may not send or receive a prescription copy for a controlled substance.
(e) The pharmacist or certified pharmacy technician receiving a prescription copy from a certified pharmacy technician must document the full names of the sending technician and the technician's supervising pharmacist. The receiving technician shall immediately reduce the prescription copy to writing, which may include entering the information directly into a computerized record keeping system, and shall review the prescription with the pharmacist on duty. Prior to dispensing, positive identification of the certified pharmacy technician and the pharmacist on duty shall be recorded to identify the responsibility for the receipt of the copy.
(f) The pharmacist or certified pharmacy technician sending a prescription copy to a certified technician must document the full names of the receiving technician and the technician's supervising pharmacist.
(g) The certified technician and the pharmacist on duty must meet all other applicable rules for the transfer of a prescription copy pursuant agency 4729 of the Administrative Code.
(15) Contacting a prescriber or prescriber's agent to obtain clarification for a prescription order if the clarification does not require the exercise of professional judgment.
(16) Performing diagnostic laboratory testing pursuant to agency 4729 of the Administrative Code.
(D) A certified pharmacy technician may:
(1) Engage in remote entry of prescriptions in accordance rule 4729:5-5-25 of the Administrative Code; or
(2) Engage in remote entry of medication orders in accordance with rule 4729:5-9-02.15 of the Administrative Code.
(E) In order to perform non-sterile drug compounding, a certified pharmacy technician shall complete the following training requirements prior to compounding non-sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <795>.
(2) Non-sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(3) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(4) Ensuring certified pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(5) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(F) In order to perform sterile drug compounding, a certified pharmacy technician shall complete the following training requirements prior to compounding sterile preparations:
(1) Training shall comply with the requirements set forth in the United States pharmacopeia chapter <797>.
(2) Sterile drug compounding training shall be obtained through completion of a site-specific, structured on-the-job didactic and experiential training program and shall not be transferable to another practice site, except between practice sites under common ownership and control.
(3) When the responsible person or a pharmacist designated by the responsible person is satisfied with the employee's knowledge and proficiency, the responsible person or the responsible person's designee will sign the documentation records to show that the employee was appropriately trained in accordance with this rule.
(4) Ensuring certified pharmacy technicians are properly trained shall be the responsibility of the terminal distributor of dangerous drugs and the licensee's responsible person.
(5) All training requirements set forth in this paragraph shall be appropriately documented and made readily retrievable for immediate inspection by an agent of the state board of pharmacy. Documentation shall be maintained by the terminal distributor of dangerous drugs for a minimum of three years.
(G) A terminal distributor of dangerous drugs and the licensee's responsible person shall be responsible for the implementation of policies and procedures for additional training appropriate to duties and responsibilities performed by a certified pharmacy technician as well as an ongoing quality assurance plan to ensure competency.
Last updated April 1, 2022 at 8:30 AM
History
- Effective: April 1, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:5-5-01
As used in Chapter 4729:5-5 of the Administrative Code:
(A) "Audit trail" means all materials and documents required for the entire processing of a prescription, which shall be sufficient to document or reconstruct the origin of the prescription and authorization of subsequent modifications of that prescription.
(B) "Dispense" means the final association of a drug with a particular patient pursuant to a prescription, drug order, or other lawful order of a prescriber and the professional judgment of and the responsibility for interpreting, preparing, compounding, labeling, and packaging a specific drug.
(C) "OARRS report" means a report of information related to a specific person generated by the drug database established and maintained pursuant to section 4729.75 of the Revised Code.
(D) "Original prescription" means any of the following issued in accordance with division 4729:5 of the Administrative Code:
(1) A prescription issued by a prescriber in writing;
(2) An oral prescription transcribed by a pharmacist, pharmacy intern, or certified pharmacy technician;
(3) An electronically transmitted prescription; or
(4) A prescription transmitted by use of a facsimile machine.
(E) "Personal supervision" or "direct supervision" means a pharmacist shall be physically present in the pharmacy, or in the area where the practice of pharmacy is occurring, to provide personal review and approval of all professional activities.
(F) "Pharmacy," except when used in a context that refers to the practice of pharmacy, means any area, room, rooms, place of business, department, or portion of any of the foregoing where the practice of pharmacy is conducted.
(G) "Pharmacist" means an individual who holds a current pharmacist license pursuant to Chapter 4729. of the Revised Code.
(H) "Outpatient pharmacy" means any pharmacy, including a clinic pharmacy, where drugs are dispensed for outpatient use. It does not include institutional pharmacies or institutional facilities, as defined in agency 4729 of the Administrative Code, where drugs are dispensed for use by inpatients. An outpatient pharmacy shall comply with all requirements set forth in this chapter.
(I)
(1) "Positive identification" means a method of identifying a person that does not rely on the use of a private personal identifier such as a password, but must use a secure means of identification that includes any of the following, as authorized under this chapter of the Administrative Code:
(a) A manual signature on a hard copy record;
(b) A magnetic card reader;
(c) A bar code reader;
(d) A biometric method;
(e) A proximity badge reader;
(f) A board approved system of randomly generated personal questions;
(g) A printout of every transaction that is verified and manually signed within a reasonable period of time by the individual who performed the action requiring positive identification. The printout must be maintained for three years and made readily retrievable; or
(h) Other effective methods for identifying individuals that have been approved by the board.
(2) A method relying on a magnetic card reader, a bar code reader, a proximity badge reader, or randomly generated questions for identification must also include a private personal identifier.
(J) "Practice of pharmacy" has the same meaning as in division (B) of section 4729.01 of the Revised Code.
(K) "Readily retrievable" means that records maintained in accordance with this chapter shall be kept in such a manner that, upon request, they can be produced for review no later than three business days to an agent, officer or inspector of the board.
(L) "Responsible person" has the same meaning as defined in rule 4729:5-2-01 of the Administrative Code and is responsible for the supervision and control of dangerous drugs as required in division (B) of section 4729.55 of the Revised Code, adequate safeguards as required in division (C) of section 4729.55 of the Revised Code, security and control of dangerous drugs, and maintaining all drug records otherwise required.
Last updated July 7, 2025 at 7:21 PM
History
- Effective: July 7, 2025
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-1-01
As used in this division:
(A) "Abandoned application" means an application for a registration pursuant to this division where the applicant fails to complete all application requirements within thirty days after being notified by the board. An applicant forfeits all fees associated with an abandoned application. The board shall not be required to act on any abandoned application and the application may be destroyed by board staff. If the application is abandoned, the applicant shall be required to reapply for registration, submit the required fee, and comply with the registration requirements in effect at the time of reapplication.
(B) "Addicted to or abusing alcohol or drugs" means the chronic and habitual use of alcohol or the use of a drug of abuse as defined in section 3719.011 of the Revised Code by an individual to the extent that the individual no longer can control the individual's use of alcohol or drugs, the individual is physically or psychologically dependent on alcohol or drugs, or the individual's use or abuse of alcohol or drugs endangers the health, safety, or welfare of the individual or others.
(C) "Board of pharmacy" or "board" means the state board of pharmacy established under Chapter 4729. of the Revised Code.
(D) "Business day" means any day other than Saturday, Sunday or a holiday recognized by the state of Ohio on which the offices of the board of pharmacy are not open for business.
(E) "Certified pharmacy technician" means a person who:
(1) Has completed an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code or has complied with the reciprocity requirements of 4729:3-2-01 of the Administrative Code;
(2) Is registered with the state board of pharmacy;
(3) Practices in this state in accordance with rule 4729:3-3-04 of the Administrative Code; and
(4) Maintains a current pharmacy technician certification from an organization that has been recognized by the board.
(F) "Compounding" has the same meaning as defined in section 4729.01 of the Revised Code and agency 4729 of the Administrative Code.
(G) "Controlled substance" has the same meaning as in section 3719.01 of the Revised Code.
(H) "Current pharmacy technician certification from an organization that has been recognized by the board" pursuant to division (B)(2)(d) of section 4729.90 of the Revised Code means either:
(1) The ExCPT certification provided by the national healthcareer association; or
(2) The pharmacy technician certification board (PTCB) certification.
(I) "Dangerous drug" has the same meaning as in section 4729.01 of the Revised Code.
(J) "Disciplinary action," unless otherwise stated in this division, means any of the following by the drug enforcement administration or licensing agency of any state or jurisdiction, regardless of whether the action occurred by formal proceeding, consent, settlement, or other agreement:
(1) An action to revoke, suspend, restrict, limit, or refuse to grant or renew a license, registration, or certification;
(2) A summary or emergency suspension of a license, registration or certification, of any length, and any subsequent revision to the action;
(3) An administrative fine or money penalty, taken as a result of a formal proceeding, to include any fine or money penalty connected to the delivery of health care services or taken in conjunction with other adverse licensure, registration or certification actions, such as revocation, suspension, censure, reprimand, or probation;
(4) An action to reprimand or place the license, registration, or certification holder on probation;
(5) The issuance of a corrective action plan only if such issuance is in conjunction with other adverse licensure, registration or certification actions, such as revocation, suspension, reprimand, probation, or surrender;
(6) The withdrawal of a renewal application for licensure, registration or certification while under investigation;
(7) The non-renewal of a license, registration or certification while under investigation or to avoid an investigation;
(8) The surrender or other relinquishment of a license, registration or certification in lieu of a formal sanction against a person's license, registration, or certificate, whether permanent or temporary;
(9) In lieu of an adverse licensure, registration or certification action, a licensing agency issues a consent order in which a person agrees not to re-apply for a license, registration, or certification in the future;
(10) An enforceable agreement not to practice or to be placed into inactive or other equivalent status while under investigation or in exchange for not conducting an investigation.
(K) "Direct supervision" or "personal supervision" means a pharmacist shall be physically present in the pharmacy, or in the area where the practice of pharmacy is occurring, to provide personal review and approval of all professional activities. The pharmacist providing personal supervision of a pharmacy technician trainee, registered pharmacy technician, or certified pharmacy technician shall:
(1) Be readily available to answer questions of the technician or trainee;
(2) Make appropriate in-process and end-process verifications of the activities of the technician or trainee; and
(3) Be fully responsible for the practice of the technician or trainee.
(L) "Entering information into and retrieving information from a database or patient profile" as used in section 4729.91 of the Revised Code means to enter new or refill prescription information into a database or patient profile.
(M) "In good standing" means a pharmacist to which all the following apply:
(1) Has not been denied the privilege of supervising pharmacy interns, certified pharmacy technicians, registered pharmacy technicians or pharmacy technician trainees by the board;
(2) Has not been denied a license, registration or certificate by any public agency or licensing agency; and
(3) Does not have a license, registration or certificate limited, suspended, currently on probation, or revoked by any public agency or licensing agency.
(N) "Pharmacist" means an individual who holds a valid pharmacist license in accordance with Chapter 4729. of the Revised Code.
(O) "Pharmacy technician trainee" means a person who:
(1) Intends to enroll or is enrolled in an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code to obtain a registration as a registered or certified pharmacy technician;
(2) Is registered as a pharmacy technician trainee with the state board of pharmacy; and
(3) Practices in this state in accordance with rule 4729:3-3-01 of the Administrative Code.
(P) "Place on probation" means to take action against a license or registration, for a period of time determined by the board, which imposes conditions or other requirements, or suspends or otherwise restricts some or all of the activities in which the licensee or registrant may engage.
(Q)
(1) "Positive identification" means a method of identifying a person that does not rely solely on the use of a private personal identifier such as a password, but must use a secure means of identification that includes any of the following:
(a) A manual signature on a hard copy record;
(b) A magnetic card reader;
(c) A bar code reader;
(d) A biometric method;
(e) A proximity badge reader;
(f) A board approved system of randomly generated personal questions;
(g) A printout of every transaction that is verified and manually signed within a reasonable period of time by the individual who performed the action requiring positive identification. The printout must be maintained for three years and made readily retrievable; or
(h) Other effective methods for identifying individuals that have been approved by the board.
(2) A method relying on a magnetic card reader, a bar code reader, a proximity badge reader, or randomly generated questions for identification must also include a private personal identifier, such as a password, for entry into a secure mechanical or electronic system.
(R) "Refill authorization" means authorization from a prescriber or prescriber's agent for a new non-controlled substance prescription renewal, provided that the prescription remains unchanged.
(S) "Refuse to grant or renew" means to deny original or continued licensure or registration for a period of at least twenty-four months. After twenty-four months, or such period of time as the individual board order may require, a person licensed or registered by the board or a person seeking to attain such status by licensure or registration, and whose license or registration the state board of pharmacy has refused to grant or renew, may make application to the board for issuance of a new license or registration. A person that seeks to attain such status by licensure or registration, whose license or registration the state board of pharmacy has refused to grant or renew, must meet all requirements established by the board in rule and as may be set forth in the person's board order.
(T) "Registered pharmacy technician" means a person who:
(1) Has completed an approved training program pursuant to rule 4729:3-3-02 of the Administrative Code or has complied with the reciprocity requirements of 4729:3-2-01 of the Administrative Code;
(2) Is registered with the state board of pharmacy; and
(3) Practices in this state in accordance with rule 4729:3-3-03 of the Administrative Code.
(U) "Responsible person" has the same meaning as defined in rule 4729:5-2-01 of the Administrative Code.
(V) "Revoke" means to take action against a license or registration rendering such license or registration void and such license or registration shall not be reissued. Revoke is an action that is permanent against the licensee or registrant.
(W) "State" means a state of the United States, the District of Columbia, the Commonwealth of Puerto Rico or a territory or insular possession subject to the jurisdiction of the United States.
(X)
(1) "Support personnel" means the following:
(a) An individual employed or performing contracted services at a location licensed as a terminal distributor of dangerous drugs, trained to perform clerical duties associated with the practice of pharmacy, including pricing, cashiering, drug purchasing, delivering, scheduling deliveries, answering non-professional telephone inquiries, transportation of dispensed medications within a hospital, documenting and processing third-party billing information for reimbursement, or any other activity as determined by the board.
(b) An individual contracted by a terminal distributor of dangerous drugs to perform drug inventories.
(2) Except for those responsible for the delivery of dangerous drugs, support personnel shall not have unsupervised access to dangerous drugs.
(3) Except as provided in paragraphs (X)(4) and (X)(5) of this rule or as otherwise authorized by the board in agency 4729 of the Administrative Code, support personnel shall not perform the tasks of a pharmacist, pharmacy intern, certified pharmacy technician, registered pharmacy technician, or pharmacy technician trainee.
(4) Support personnel may have access to or retrieve information from patient records, including a database or patient profile to perform clerical duties associated with the practice of pharmacy. Support personnel shall not enter prescription information into a patient profile.
(5) Support personnel may perform the following:
(a) Transporting dangerous drugs from a loading dock, warehouse or other area that receives shipments from a licensed wholesaler or other person licensed in accordance with section 4729.52 of the Revised Code;
(b) Stocking and retrieving from inventory non-controlled dangerous drugs that are not dispensed by the pharmacy.
(c) Stocking of automated drug dispensing units and floor stock with intravenous fluids that are non-controlled dangerous drugs and are not dispensed by an institutional pharmacy.
(d) Overwrapping or placing in plastic dangerous drugs that have been compounded or dispensed and appropriately labeled by a terminal distributor of dangerous drugs.
(e) Entering demographic and insurance information into an electronic system to process prescription claims.
(f) Place dangerous drugs dispensed by a pharmacist into shipping containers or packages for delivery if the terminal distributor of dangerous drugs complies with all the following:
(i) Uses barcode scanning and patient order information to ensure the accuracy of the drugs placed into shipping containers or packaging.
(ii) Develops and implements a quality assurance program to track the accuracy of the support personnel packaging the dangerous drugs.
(6) The terminal distributor of dangerous drugs shall be responsible for ensuring all support personnel comply with state and federal requirements to ensure the confidentiality of patient health records.
(7) Support personnel shall not serve as a pharmacist's delegate pursuant to section 4729.80 of the Revised Code.
(8) Support personnel are not required to obtain licensure or registration under Chapter 4729. of the Revised Code.
(Y) "Suspend" means to take action against a license or registration rendering such license or registration without force and effect for a period of time as determined by the state board of pharmacy.
(Z) "Summary suspension" means to take immediate action against a license or registration without a prior hearing rendering such license or registration without force and effect for a period of time as indicated in section 3719.121 of the Revised Code. The board may suspend a license or registration issued pursuant to Chapter 4729. of the Revised Code by utilizing a telephone conference call to review the allegations and take a vote.
(AA) "Veteran" means anyone who is serving or has served under honorable conditions in any component of the armed forces, including the national guard and reserve.
Last updated April 1, 2022 at 8:28 AM
History
- Effective: April 1, 2022
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-05 Certified pharmacy technician administration of diagnostic tests.
(A) A certified pharmacy technician under the direct supervision of a pharmacist may administer clinical laboratory improvement amendments (CLIA) waived diagnostic laboratory testing provided the following conditions are met:
(1) The pharmacy or facility licensed as a terminal distributor of dangerous drugs is certified by the United States department of health and human services (HHS), as a clinical laboratory through the CLIA;
(2) The pharmacy or facility licensed as a terminal distributor of dangerous drugs has obtained a CLIA certificate of waiver from HHS; and
(3) The responsible person of the terminal distributor of dangerous drugs and the terminal distributor of dangerous drugs shall ensure and document that all certified pharmacy technicians conducting CLIA waived tests pursuant to this rule receive appropriate training to conduct testing in a safe and effective manner.
(B) This rule applies only to the administration and evaluation of laboratory testing by individuals licensed or registered in accordance with Chapter 4729. of the Revised Code.
Last updated October 22, 2025 at 11:13 AM
History
- Effective: January 1, 2020
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-3-06 Immunization administration.
(A) A certified or registered pharmacy technician who meets the requirements of paragraph (B) of this rule and is working under the direct supervision of a pharmacist who meets the requirements of rule 4729:1-3-02 of the Administrative Code, may administer to an individual who is five years of age or older an immunization for any disease, including an immunization for influenza or COVID-19.
(B) For a certified or registered pharmacy technician to be authorized to engage in the administration of immunizations, the technician shall comply with all the following requirements:
(1) Complete a practical training program that meets the requirements set forth in paragraph (C) of this rule.
(2) Administer immunizations authorized by a prescriber-established protocol that meets the requirements of rule 4729:1-3-02 of the Administrative Code.
(3) Be authorized by the supervising pharmacist to administer immunizations. The pharmacist supervising the technician may prohibit, limit, or restrict the type of immunizations administered, including the age of the patient, by the technician.
(4) Receive and maintain certification to perform basic life-support procedures by successfully completing a basic life-support training course certified by the American red cross, American heart association, American safety and health institute, or other training course approved by the board. Certification shall be obtained and maintained through courses that are conducted in- person or, at a minimum, offer an in-person or electronic hands-on training component.
(5) The pharmacist on duty who is supervising the technician shall be on-site to administer epinephrine or diphenhydramine, or both, to individuals in emergency situations resulting from adverse reactions to the immunizations administered by the registered or certified pharmacy technician.
(6) The pharmacist on duty who is supervising the technician determines if the technician is competent to administer immunizations.
(C) A course in the administration of immunizations developed pursuant paragraph (B) of this rule shall meet the following requirements:
(1) The instructor shall be a licensed health care professional and have the appropriate education and experience to teach a course in the administration of immunizations.
(2) The content must meet the standards established for such courses by the centers for disease control and prevention in the public health service of the United States department of health and human services.
(3) The course shall be conducted by an accreditation council for pharmacy education (ACPE) accredited provider.
(4) The course must be a minimum of six hours in length and include, at a minimum, the following topic areas:
(a) A review of immunology that includes a discussion of the body's immune system reaction to immunizations.
(b) A review of each immunization recommended by the advisory committee on immunization practices of the centers for disease control and prevention in the United States department of health and human services (6/28/2024):
(i) Disease states associated with the immunization;
(ii) Type or nature of activity of the immunization;
(iii) Administration schedules;
(iv) Routes of administration;
(v) Injection sites;
(vi) Dosages;
(vii) Monitoring and treatment of the patient for adverse reactions;
(viii) Patient populations;
(ix) Precautions and contraindications; and
(x) Proper storage requirements for the immunization.
(c) A review of sterile technique in injectable dosage preparation and administration.
(d) A minimum of one hour of instruction and physical participation in administration techniques.
(e) A review of the proper disposal procedures for contaminated needles and immunizations.
(f) A review of the proper procedures for accidental needle sticks.
(5) The course must provide a method to evaluate the successful comprehension of the content.
(6) The course must provide a method to demonstrate the participant has successfully completed the course.
(D) Courses on immunization administration may be reviewed by the state board of pharmacy. A training course that fails to comply with the requirements set forth in this rule shall be considered in violation of this rule.
(E) The pharmacy employing the technician shall ensure informed consent is obtained pursuant to rule 4729:5-5-04 of the Administrative Code prior to the administration of an immunization.
(F) The pharmacy employing the technician shall ensure the technician maintains the competency and skills necessary to safely administer immunizations. The pharmacy shall ensure the technician has initial and annual documented assessment of competency in immunization administration.
(G) Immunization records shall be maintained in accordance with rule 4729:5-5-04 of the Administrative Code.
(H) The pharmacy where a technician is administering immunizations in accordance with this rule shall comply with the vaccine information statement requirements of the National Vaccine Childhood Injury Act, 42 USC Section 300aa-26 (12/14/1993).
(I) For each immunization administered to an individual by a certified or registered pharmacy technician, other than an immunization for influenza administered to an individual eighteen years of age or older, the pharmacy employing the technician shall be responsible for ensuring the notification of the individual's primary care provider or, if the individual has no primary care provider, the board of health of the health district in which the individual resides or the authority having the duties of a board of health for that district under section 3709.05 of the Revised Code. The notice shall be given not later than thirty days after the immunization is administered. Notification shall be conducted using one of the following methods that is capable of confirming delivery of the required notification:
(1) Electronic mail;
(2) Interoperable electronic medical records system;
(3) Facsimile;
(4) Electronic prescribing system;
(5) Electronic pharmacy record system;
(6) Reporting to the state's immunization registry;
(7) Documented verbal communication; or
(8) Any other method of notification that might reasonably be expected to allow for the confirmed transmission of the required notification.
(J) For each immunization administered by a certified pharmacy technician or registered pharmacy technician to an individual who is younger than eighteen years of age, the certified pharmacy technician or registered pharmacy technician shall inform the individual's parent or legal guardian of the importance of well child visits with a pediatrician or other primary care provider and shall refer patients when appropriate.
(K) The pharmacy employing a certified or registered technician authorized to provide immunizations in accordance with this rule, shall maintain, or have immediate access to, the following records on file at the location(s) where the pharmacy technician administers immunizations in accordance with this rule:
(1) Proof of successful completion of a training course specified in paragraph (C) of this rule;
(2) Proof of maintenance of certification to perform basic life-support procedures in accordance with paragraph (B)(4) of this rule; and
(3) Proof of competency assessments as required in paragraph (F) of this rule.
(L) A pharmacist practicing within an outpatient pharmacy shall not supervise more than three pharmacy personnel engaged in the administration of immunizations pursuant to this rule and rule 4729:2-3-03 of the Administrative Code.
(M) A pharmacist supervising an immunization clinic outside of an outpatient pharmacy shall not supervise more than six pharmacy personnel engaged in the administration of immunizations pursuant to this rule and rule 4729:2-3-03 of the Administrative Code.
Last updated May 19, 2025 at 8:01 AM
History
- Effective: May 19, 2025
- Promulgated Under: 119.03
Chapter 4729:3-4 Discipline and Duty to Report
Ohio Adm.Code 4729:3-4-01 Disciplinary actions.
(A) As used in this rule:
(1) "Dishonesty" means any action by a licensee, registrant or applicant to include, but is not limited to, making any statement that deceives, misrepresents or misleads, or be a party to or an accessory to any fraudulent or deceitful practice or transaction in the practice of pharmacy or in the operation or conduct of a pharmacy.
(2) "Unprofessional conduct" means conduct that is detrimental to the best interests of the public, including conduct that endangers the health, safety or welfare of a patient or client. Such conduct shall include, but not be limited to, the following acts: coercion, intimidation, harassment, sexual harassment, improper use of private health information, threats, degradation of character, indecent or obscene conduct, and theft.
(3) "Reckless behavior" means a person who acts recklessly or who is reckless. A person acts recklessly when, with heedless indifference to the consequences, the person disregards a substantial and unjustifiable risk that the person's conduct is likely to cause a certain result or is likely to be of a certain nature. A person is reckless with respect to circumstances when, with heedless indifference to the consequences, the person disregards a substantial and unjustifiable risk that such circumstances are likely to exist.
(B) The state board of pharmacy, after notice and hearing in accordance with Chapter 119. of the Revised Code, may impose one or more of the following sanctions on a pharmacy technician trainee, registered pharmacy technician, certified pharmacy technician or applicant for such registration if the board finds the individual engaged in any of the conduct set forth in paragraph (C) of this rule:
(1) Revoke, suspend, restrict, limit, or refuse to grant or renew a registration;
(2) Reprimand or place the holder of the registration on probation;
(3) Impose a monetary penalty or forfeiture not to exceed in severity any fine designated under the Revised Code for a similar offense, or in the case of a violation of a section of the Revised Code that does not bear a penalty, a monetary penalty or forfeiture as specified in section 4729.96 of the Revised Code.
(C) The board may impose the sanctions listed in paragraph (B) of this rule if the board finds a pharmacy technician trainee, registered pharmacy technician, certified pharmacy technician or applicant for such registration:
(1) Except as provided in paragraph (C)(9) of this rule, has engaged in any of the conduct specified in division (A)(2) of section 4729.96 of the Revised Code.
(2) Violated any state or federal law or rule regardless of the jurisdiction in which the acts were committed, except for minor traffic violations such as parking violations, speeding tickets and violations such as failure to obey a red light, failure to use a turn signal or expired registration.
(3) Has been disciplined by the state board of pharmacy pursuant to section 4729.96 of the Revised Code.
(4) Has been the subject of any of the following by the drug enforcement administration or licensing agency of any state or jurisdiction:
(a) A disciplinary action that resulted in the suspension, probation, surrender or revocation of the person's license or registration.
(b) A disciplinary action that was based, in whole or in part, on the person's inappropriate prescribing, dispensing, diverting, administering, storing, securing, personally furnishing, compounding, supplying or selling a controlled substance or other dangerous drug.
(5) Has been subject to any of the following:
(a) A finding by a court of the person's eligibility for intervention in lieu of conviction; or
(b) A finding by a court of the person's eligibility for treatment or intervention in lieu of conviction in another jurisdiction.
(6) Has been granted entry into a diversion program, deferred prosecution program, or the equivalent thereof.
(7) Cannot conduct authorized activities according to acceptable and prevailing standards of care by reason of mental illness or physical illness, including, but not limited to, physical deterioration that adversely affects cognitive, motor, or perceptive skills.
(8) Engaged in dishonesty or unprofessional conduct.
(9) Is responsible for any of the following but only as a result of reckless behavior:
(a) An error in dispensing as defined in rule 4729:5-3-22 of the Administrative Code;
(b) A product quality issue for any compounded drug preparation as defined in rule 4729:7-2-03 of the Administrative Code.
(D) The board may require that an individual whose registration has been suspended may not be employed by or work in a facility licensed by the state board of pharmacy to possess or distribute dangerous drugs during such period of suspension.
Last updated March 4, 2025 at 7:59 AM
History
- Effective: March 1, 2025
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-4-02 Duty to Report.
(A) As used in this rule, "error in dispensing" or "dispensing error" has the same meaning as rule 4729:5-3-22 of the Administrative Code.
(B) Pursuant to section 4729.10 of the Revised Code, a pharmacy technician trainee, registered pharmacy technician or certified pharmacy technician who has knowledge, from direct observation or objective evidence, of violations described in paragraph (C) of this rule shall report such conduct to the board.
(C) The following shall be reported to the board no later than ten days from discovery:
(1) Except as provided in paragraphs (C)(1)(a) and (C)(1)(b) of this rule, conduct indicating an individual licensed or registered by the board is practicing pharmacy while physically or mentally impaired by alcohol, drugs or other chemical substances or impaired physically or mentally to such a degree as to render the individual unfit to carry out their professional duties.
(a) A registrant shall not be required to report in accordance with this rule if the registrant becomes aware of any condition described in paragraph (C)(1) of this rule as a result of either:
(i) The registrant or licensee is involved in the treatment of the individual for the condition; or
(ii) The registrant or licensee having access to the individual's protected health information.
(b) A registrant shall not be required to report in accordance with this rule if the individual voluntarily seeks treatment for a mental health condition or substance use disorder and there are no other violations of rule or law.
(2) Except as provided in paragraph (H) of this rule, violations, attempts to violate, or aiding and abetting in the violation of any of the provisions of Chapters 4729., 3715., 3719., 2925., and 2913. of the Revised Code, or any rule adopted by the board under those provisions, by an individual licensed or registered by the board.
(3) Conduct by a pharmacy technician trainee, registered pharmacy technician, certified pharmacy technician, pharmacy intern or pharmacist that constitutes unprofessional conduct or dishonesty as defined in rule 4729:3-4-01 of the Administrative Code.
(D)
(1) Pursuant to section 4729.23 of the Revised Code, the identity of the registrant making a report in accordance with this rule shall remain confidential.
(2) Notwithstanding the confidentiality provided in accordance with paragraph (D)(1) of this rule, a registrant may be required to testify in a disciplinary proceeding as to the conduct or violations listed in paragraph (C) of this rule without disclosing the registrant was the reporting individual.
(E) Reporting required in accordance with paragraph (C) this rule shall be made by mail, using the board's online complaint form (available on the board's web site: www.pharmacy.ohio.gov), or by telephone and shall include the following information:
(1) The name of the licensee or registrant or other individual who may have committed a violation listed in paragraph (C) of this rule;
(2) The violation which is believed to have occurred; and
(3) The date(s) of and place(s) of occurrence(s), if known.
(F) All reports submitted in accordance with this rule shall protect the confidentiality of patients. The board may request additional information, including patient information, as part of an investigation conducted in accordance with Chapter 4729. of the Revised Code.
(G) An individual registered pursuant to this division shall notify the board of any of the following:
(1) Any criminal conviction for, judicial finding of guilt of, or plea of guilty to a disqualifying offense within ten days after the date of conviction.
(2) The registrant is convicted of, plead guilty to, is subject to a judicial finding of eligibility for intervention in lieu of conviction in this state under section 2951.041 of the Revised Code or the equivalent thereof in another jurisdiction within ten days after the individual is deemed eligible.
(3) The registrant is granted entry into a diversion program, deferred prosecution program, or the equivalent thereof within ten days after the individual is granted entry into a program.
(4) Any arrest for a felony within ten days after the arrest.
(5) For a certified pharmacy technician, failure to maintain a current pharmacy technician certification from an organization that has been recognized by the board.
(H) An individual registered pursuant to this division shall notify the board of any disciplinary licensing or registration action taken by another state against the registrant within ten days of the notice of action. This includes, but is not limited to, a disciplinary action that is stayed pending appeal.
(I) A dispensing error, as defined in rule 4729:5-3-22 of the Administrative Code, shall only be reported to the board by a pharmacy in accordance with rule 4729:5-4-02 of the Administrative Code.
(J) Pursuant to section 4729.10 of the Revised Code, in the absence of fraud or bad faith, a person who reports in accordance with this rule or testifies in any adjudication conducted under Chapter 119. of the Revised Code is not liable to any person for damages in a civil action as a result of the report or testimony.
Last updated March 4, 2025 at 8:00 AM
History
- Effective: March 1, 2025
- Promulgated Under: 119.03
Chapter 4729:3-5 Continuing Education
Ohio Adm.Code 4729:3-5-01 Continuing education - definitions.
As used in Chapter 4729:3-5 of the Administrative Code.
(A) "A.C.P.E." means the accreditation council for pharmacy education.
(B) "Continuing education unit" or "C.E.U." means ten contact hours of participation in an organized continuing pharmacy education experience presented by an approved provider.
(C) "Continuing pharmacy education" or "continuing education", as required in section 4729.12 of the Revised Code, means post-registration pharmacy education undertaken to maintain professional competency to practice as a pharmacy technician, improve professional skills, and preserve uniform qualifications for continuing the practice of the profession for the purpose of protecting public health and welfare. Continuing pharmacy education may be obtained from any of the following providers:
(1) A pharmacy jurisprudence program pursuant to paragraph (E) of this rule;
(2) An approved in-state provider of volunteer healthcare services in accordance with section 4745.04 of the Revised Code and Chapter 4729-6 of the Administrative Code;
(3) An A.C.P.E. accredited continuing education provider.
(D) "One-third of a licensee's continuing education requirement" as used in division (C) of section 4745.04 of the Revised Code and paragraph (C) of rule 4729:3-5-02 of the Administrative Code, means the total number of required C.E.U.s for licensure renewal divided by three and rounded down to the nearest whole number.
(E) "Pharmacy jurisprudence" means continuing education the includes any of the following:
(1) An A.C.P.E. law program as identified by A.C.P.E numbering convention "03";
(2) A board of pharmacy approved continuing education program provided by an in-state approved jurisprudence provider pursuant to Chapter 4729-6 of the Administrative Code that pertains to current or recent changes to laws, rules, and regulations relating to the practice of pharmacy; or
(3) A program presented by the state board of pharmacy that pertains to current or recent changes to laws, rules, and regulations relating to the practice of pharmacy.
(F) "Patient or medication safety" means an A.C.P.E. continuing education program identified by the A.C.P.E. numbering convention "05" that pertains to the prevention of healthcare errors and the elimination or mitigation of patient injury caused by healthcare errors.
(G) "Veteran" means anyone who is serving or has served under honorable conditions in any component of the armed forces, including the national guard and reserve.
Last updated May 15, 2026 at 7:33 AM
History
- Effective: May 15, 2026
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-5-02
(A) As a condition for the renewal of a registration as a registered pharmacy technician, the registrant shall complete a total of ten contact hours (1.0 C.E.Us) of continuing pharmacy education during the twenty-four months preceding the expiration date of the technician's registration. The continuing pharmacy education shall be in pharmacy technician-specific subject matter and shall include, at a minimum, the following:
(1) Two contact hours (0.2 C.E.Us) of continuing pharmacy education shall be in the subject of pharmacy jurisprudence (law).
(2) Two contact hours (0.2 C.E.Us) of continuing pharmacy education shall be in the subject of patient or medication safety.
(B) Paragraph (A) of this rule does not apply to registered pharmacy technicians that obtain an initial registration within six months of the expiration date of the registration.
(C) A registered pharmacy technician may satisfy up to one-third of the technician's continuing education requirements by providing health care services as a volunteer in accordance with section 4745.04 of the Revised Code. The location where health care services are provided shall be an approved in-state provider of volunteer healthcare services in accordance with Chapter 4729-6 of the Administrative Code.
(D) Registered pharmacy technicians shall keep all certificates and other documented evidence of participation which have been issued by a non-A.C.P.E. accredited provider for which the pharmacy technician has claimed continuing education units towards renewal of the technician's registration for a period of one year following the year in which evidence was required for renewal.
(1) Documentation, as determined by the state board of pharmacy, shall be submitted only when requested by the board.
(2) The board shall monitor compliance by conducting an audit of registrants.
(3) The board shall require the reporting of continuing education units to a national and/or state register.
(E) As a condition for the renewal of a registration as a certified pharmacy technician, the registrant shall complete all continuing education requirements necessary to maintain the registrant's pharmacy technician certification from an organization that has been recognized by the board.
Last updated May 15, 2026 at 7:33 AM
History
- Effective: May 15, 2026
- Promulgated Under: 119.03
Ohio Adm.Code 4729:3-5-03 Veteran and military family provisions related to continuing education.
(A) Extension of continuing education requirements.
(1) In accordance with section 5903.12 of the Revised Code, the state board of pharmacy shall grant extension periods and waivers for the completion of continuing education requirements for active duty veteran members and the spouses of active duty veterans. If a registered pharmacy technician or their spouse is called to active duty for military service, the time period allowed for completion of any continuing education requirements will be extended by the amount of time that the technician or the technician's spouse was on active duty.
(2) Upon receiving the application and proper documentation, the board's executive director or director's designee shall extend the continuing education reporting period by an amount of time equal to the total number of months that the registrant or their spouse spent on active duty during the current reporting period. For purposes of this division, any portion of a month served on active duty shall be considered one full month.
(3) The registrant shall submit proper documentation certifying the active duty service and the length of that active duty service. Documentation required to obtain an extension or waiver pursuant to paragraph (A)(1) of this rule will be published on the state board of pharmacy's website: www.pharmacy.ohio.gov.
(B) Determining fulfillment of continuing education.
(1) If a registered pharmacy technician is a veteran, the state board of pharmacy shall consider relevant military education, training or service that has been completed by the registration holder no more than two years prior to the thirty first of march of the year in which a technician's registration must be renewed when determining the fulfillment of any continuing education requirements.
(2) For the board to consider relevant education, training, or service completed by a registered technician, the registrant shall submit a request for consideration and evidence or documentation of the education, training, or service to the executive director or director's designee at least thirty days prior to the required continuing education reporting period pursuant to rule 4729:3-5-02 of the Administrative Code.
Last updated May 19, 2025 at 8:01 AM
History
- Effective: May 19, 2025
- Promulgated Under: 119.03
Continue your research in ChatGPT or Claude
Connect Omnilex to search the legal corpus from your AI assistant.